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Abstract
The importance of CD8+ T cells in the control of HIV/SIV infection has been extensively reported.
However, the reason why CD8+ T cells do not sufficiently control or clear virus is unknown. Importantly,
cytolytic properties of CD8+ T cells are highly correlated with control of HIV/SIV infection as
demonstrated in elite controller subjects yet are poorly maintained in chronically infected subjects. In
addition, reduced killing functions by lymph node CD8+ T cells as compared to blood CD8+ T cells have
been described during chronic HIV infection suggesting a semi-immune privilege environment of lymph
nodes. To date, the evolution of cytolytic SIV-specific CD8+ T cells in anatomical compartments
associated with viral reservoir and replication has not been thoroughly evaluated. As such, we
implemented the Rhesus macaque SIV infection model to characterize the evolution and tissuedistribution of cytolytic SIV-specific memory CD8+ T cells during acute infection. We found robust acute
phase cytolytic potential to be short-lived, in part consequential of low levels of T-bet, in all evaluated
tissues though most pronounce in secondary lymphoid tissues. In addition, we observed the lowest
frequencies of effector memory differentiated SIV-specific CD8+ T cells within secondary lymphoid
tissues as compared to the circulation, even during peak viremia. Moreover, secondary lymphoid tissues
appear to provide an environment with reduced cytotoxic effector CD8+ T cell pressures that is favorable
for viral reservoir formation and persistent viral replication in these tissues.
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Abstract
The importance of CD8+ T cells in the control of HIV/SIV infection has been
extensively reported. However, the reason why CD8+ T cells do not sufficiently control
or clear virus is unknown. Importantly, cytolytic properties of CD8+ T cells are highly
correlated with control of HIV/SIV infection as demonstrated in elite controller subjects
yet are poorly maintained in chronically infected subjects. In addition, reduced killing
functions by lymph node CD8+ T cells as compared to blood CD8+ T cells have been
described during chronic HIV infection suggesting a semi-immune privilege environment
of lymph nodes. To date, the evolution of cytolytic SIV-specific CD8+ T cells in
anatomical compartments associated with viral reservoir and replication has not been
thoroughly evaluated. As such, we implemented the Rhesus macaque SIV infection
model to characterize the evolution and tissue-distribution of cytolytic SIV-specific
memory CD8+ T cells during acute infection. We found robust acute phase cytolytic
potential to be short-lived, in part consequential of low levels of T-bet, in all evaluated
tissues though most pronounce in secondary lymphoid tissues. In addition, we observed
the lowest frequencies of effector memory differentiated SIV-specific CD8+ T cells
within secondary lymphoid tissues as compared to the circulation, even during peak
viremia. Moreover, secondary lymphoid tissues appear to provide an environment with
reduced cytotoxic effector CD8+ T cell pressures that is favorable for viral reservoir
formation and persistent viral replication in these tissues.
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Chapter 1: Thesis Introduction
Chapter 1.1 Immunological memory and the adaptive immune system: a brief
overview
One of the most astounding aspects of the mammalian immune system is the
potential for and actualization of memory to nearly all encountered foreign antigens
termed immunological memory. This attribute of immunity affords life long recognition
and protection upon repeat exposure to foreign or altered-self antigens. Immunological
memory is a unique and key feature of vertebrate immunity that separates the adaptive
from the innate, or pre-established and fixed, arm of immune functions. As such,
immunological memory may be the most critical physiological component fostering
persistence of mammalian organisms despite the rapid evolution of pathogens such as
bacteria and viruses. Both T and B lymphocytes are cells of the adaptive immune system
that display features of immunological memory and can persist for the duration of the
host’s life following primary encounter with cognate antigen.
Chapter 1.1.1 T and B cells in Immunological memory
The CD4+ T cell, otherwise known as the helper T cell, is instrumental in
development of immunological memory by directing adaptive immune responses and
ultimately long term antigenic memory. To this end, CD4+T cells help in the selection
and activation of naive CD8+ T cells and driving subsequent effector and memory CD8+
T cell functions (1, 2). At the same time, CD4+ helper T cells are essential for the
1

selection and activation of naïve B cells as well as the intricate process of stochastically
refining the affinity of the B cell receptor for its recognized antigen within germinal
centers. Following selection, activation and help from CD4+ T cells, both B cells and
CD8+ T cells can establish immunological memory (3). To our current knowledge, B
cells and the antibodies B cells produce do not directly mediate clearance of infected or
altered-self cells, but serve as a means to opsonize or tag pathogens, pathogen infected
cells or altered-self cells for clearance by phagocytic cells of the innate immune system
such as macrophage and neutrophils. However, activated memory CD8+ T cells can
directly mediate clearance of infected or altered-self cells through direct and indirect
mechanisms that include contact dependent transfer of cytolytic factors to the target cell
or contact independent passive transfer of secreted antiviral factors (4-8).
Following clearance of a target cell, activated B cells and T cells undergo a
transition to a less activated and more quiescent memory state (9). The loss of effector
CD8+ T cells or antibody producing short-lived plasma cells following resolution of
infection contributes to immune homeostasis in the host. Nevertheless, established
memory responses can easily be reactivated upon re-exposure to the pathogen or antigen
for many years if not the remainder of the life of the organism (10-12).
Chapter 1.1.2 Application of Immunological memory
The natural phenomenon of immunological memory in response to pathogens had
been documented for thousands of years without any understanding of its etiology or
development. Even during the first vaccination strategies via inoculation of a natural but
2

less virulent strain of poxvirus, how vaccinated hosts established long-lived immunity
was unclear (13). Knowing the potential for developing life-long immunity has for years
promoted the use of vaccinations with live attenuated or heat killed pathogens by
clinicians. For many endemic pathogens, vaccination strategies have been useful in
preventing epidemics and major health complications following infection, as was seen
with small pox, measles and polio infections (13, 14). More recently, vaccinations against
oncogenic viruses have been successful in reducing the incidence of cancer related to
viral infections, most notably from Human papilloma viruses (HPV) (15, 16). However,
the unfathomable nearly perfect and beautifully orchestrated phenomenon of long-lasting
protective immunity has faltered following exposure to some pathogens including chronic
viral infections (Discussed in Chapter 1.5) and otherwise altered-self cells including
cancer (17).
This thesis characterizes the acute phase development of CD8+ T cell memory to
SIV infection in critical anatomical compartments including blood, secondary
lymphoid tissue and gut mucosa.

Chapter 1.2 Generating CD8+ T cell memory
Chapter 1.2.1 Encountering cognate antigen
Following maturation in the thymus, naïve CD8+ T cells drain to the circulating
peripheral blood en route to secondary lymphoid tissue (SLT) (lymph nodes, spleen and
gut associated lymphoid structures) in an effort to identify and interact with cognate
antigen present by an antigen presenting cell (APC) (Figure 1-1) (18). Naïve CD8+ T
3

cells diapedese, or migrate out, from the blood through high endothelial venules (HEV)
into lymphoid tissues and ultimately to the lymphatic system (19, 20). The extravasation
and trafficking of naïve and central memory CD8+ T cells to secondary lymphoid organs
through HEV is in part mediated by CD62L binding to peripheral node addressin
expressed on HEV and chemotaxis via expressed CCR7 for CCL19 and CCL21 released
by HEV (19, 20). Upon arrival in SLTs, naïve CD8+ T cells migrate through the
subcapsulary sinus into the medulla and finally to the T cell zone with the intention to
interact with cognate antigen presented on APC (21). If a naïve CD8+ T cell encounters
cognate antigen presented on MHC class I through an interaction with its T cell receptor
(TCR), CD8+ T cell differentiation beings. If a naïve CD8+ T cell otherwise fails to
encounter cognate antigen- MHC I within 7-8 hours of entering the T cell zone, the CD8+
T cell initiates egress from that structure, ultimately migrating to efferent lymphatics
(18). Within the lymphatics, a naïve CD8+ T cell may traffic to another lymphoid organ
in search for cognate antigen or return to the peripheral blood circulation via the thoracic
duct. Nevertheless, upon encounter with cognate antigen-MHC I in a SLT, naïve CD8+ T
cells become activated and being differentiation.
Whether naïve or recirculating memory CD8+ T cells encounter cognate antigen
in SLT, these recently activated CD8+ T cells migrate out of the lymphoid tissue as
recently activated and differentiated cells, move into the efferent lymph, and ultimately
re-enter the peripheral blood circulation via the thoracic duct (20). This series of events
following antigen encounter in SLT allows T cells to migrate to appropriate anatomical
sites where foreign antigen, infected self cells, or altered self cells reside.
4

Chapter 1.2.2 CD8+ T cell activation and cycling
Activation and expansion of CD8+ T cells is essential for rapid and efficient
clearance of infected cells and establishment of long-lived memory cells. Our current
understanding of optimal naïve CD8+ T cell activation and differentiation begins with
three important external signals (22-24). First, a stable interaction between TCR and
cognate antigen presented on MHC of the APC, most often dendritic cells, must occur.
Second, interaction of activating co-stimulatory receptors on T cells, such as CD28 and
ICOS, with their ligands CD80 and CD86, and ICOSL on the APC (23). These two
essential engagements, TCR with peptide-MHC and co-stimulatory receptor ligation,
generate what is known as signal 1 and signal 2, respectively, in the CD8+ T cells and
initiate activation and memory differentiation programs in these CD8+ T cells. The last
signal, signal 3, is required to direct differentiation of recently activated CD8+ T cells
towards a functional fate. These fates can include long-lived central memory CD8+ T
cells that lack effector functions or effector CD8+ T cells that maintain the capacity for
CD8+ T cell effector functions including anti-viral and anti-tumor responses. Additional
differentiation fates include regulatory or suppressive fates that are broadly defined as
anti-inflammatory (i.e. IL-10 and transforming growth factor beta (TGFβ) expressing) or
stem-cell like that are thought to maintain long-lived T cell memory (25-27).
In concert, these three signals initiate intracellular signaling cascades that drive T
cell activation (23, 24, 28). Broadly speaking, ERK/MAPK, PI3K/AKT and
Ca2+/calcineurin pathways converge in T cells to orchestrate nuclear localization of
transcription factors that initiate cell survival, growth, and proliferation, all necessary
5

steps for CD8+ T cell differentiation. Key transcription factors initiated following T cell
activation include NFκb, NFAT and AP1 among many others (23, 24). In addition,
commonly produced pro-inflammatory cytokines such as interferon gamma (IFNγ),
tumor necrosis factor (TNF), and IL-2 can be detected in recently activated T cells (26).
Production of these pro-inflammatory cytokines is important to promote survival,
differentiation and expansion of activated T cells (9, 24, 26, 29).
Surface markers commonly used to identify T cell activation include CD25 the
high affinity IL-2 receptor, for receiving survival cytokine IL-2, CD69 for tissues
retention, as well as the expression of HLA-DR on human and non-human primate CD8+
T cells, where the function of HLA-DR class II MHC on activated CD8+ T cells is
unknown. Additionally, PD-1 is upregulated in response to CD8+ T cell activation and
has functions involved in regulating T cell activation and homeostasis and can therefore
serve as a marker of T cell activation (30).
Importantly, following initiation of this activated T cell program T cells
proliferate to establish a sufficient repertoire of antigen specific T cells and subsequently
populate the effector and memory repertoire. The expression of Ki67, a surfactant
involved in chromatin decondensation, is commonly used as an indicator of entry into
cell cycling or recent completion of cycling (31).
Chapter 1.2.3 Regulation of activation
Although activation is a critical state for generating CD8+ T cells that can
exercise functional capabilities, regulation of T cell activation is critical as it is important
6

to prevent chronic activation and inflammation in the host. Chronic immune activation
and inflammation can lead to pathology, tissue damage or death of the organism (28, 3237). For example, during HIV/SIV infection, persistence of high levels of immune
activation in treatment naïve hosts results in extensive, irreversible fibrosis of SLT even
during early chronic infection. Not surprisingly, chronic immune activation increases the
risk of developing cardiovascular disease and deposition of atherosclerotic plaques (33,
38). In addition, regulation of T cell activation and cycling is important to prevent
excessive proliferation of activated T cells that otherwise may evolve into hematological
malignancies (39, 40).
In an effort to mitigate deleterious consequences of T cell activation, many layers
of regulation, including the recently focused on group of inhibitory receptors are present
following T cell activation (34). The inhibitory receptors involved in driving regulation
include CLTA-4, PD-1, Lag-2, 2B4, CD160, Tim3, and TIGIT among others (34).
Inhibitory receptors binding to ligands converge to modulate and dampen T cell
activation. In cases of chronic viral infection and cancer, the generation of exhausted
CD8+ T cells, consequential of persistent high levels of antigen stimulation and proinflammatory cytokines, is unfavorable for clearance of target cells but paradoxically
necessary for the survival of the host (41).
Despite some undesirable caveats of T cell activation during infection or cancer,
the ability to establish long-lived memory requires mitigation of T cell activation.
Moreover, the immune system depends on proper regulation of T cell activation for full
execution of immunological and adaptive functions.
7

Chapter 1.2.4 CD8+ T cells differentiation
CD8+ T cell differentiation following recent activation includes memory and
effector fates. As in many examples of cellular and organ system development, how T
cells make fate decisions to become effector or memory CD8+ T cells has not been
worked out entirely and at some level appears stochastic. However, we do know that
differentiation of effector and memory cells is influenced by inflammation via cytokine
signaling, otherwise known as signal 3 (Chapter 1.2.2) (9, 42). For example, memory
versus effector fate decision has been shown to be dependent on the pro-inflammatory
cytokine milieu determined by the innate response to the encountered pathogen or
altered-self cell (42). Pro-inflammatory signals released by innate immune, fibroblast or
directly infected cells are essential for decoding and relaying the location, and quantity of
antigen to CD8+ T cell effector cells for efficient clearance of the antigen (26, 43, 44).
Despite a lack of an agreed upon model of memory differentiation, it is certain that
effector CD8+ T cells expand to high levels immediately following encounter with
cognate antigen, either during primary or secondary responses, and memory responses
expand following clearance of the antigen and source.
Chapter 1.2.5 Effector CD8+ T cells
Following antigen exposure and T cell activation, a pool of effector CD8+ T cells
specific for the ensuing target antigen is heavily seeded in the circulation and
subsequently in infected tissues. The primary designation of effector CD8+ T cells is to
execute cell-mediated effector responses and clear target cells as rapidly as possible or to
8

inhibit viral replication. Several effector mechanisms CD8+ T cells use have been
identified. These functions fall into two major categories; cytolytic and non-cytolytic
functions. Cytolytic functions induce cell death of the target cell, whereas non-cytolytic
functions induce suppressive mechanism such as inhibition of proliferation, viral
replication, infection, migration or survival of pathogens (4-6). Nevertheless, CD8+ T
cells are the major contributing force to anti-viral and anti-tumor effector responses by
the adaptive immune system.
Several differences in effector CD8+ T cell phenotyping exist between human and
rhesus macaque (RM) primarily due to availability of macaque cross-reactive
immunophenotyping antibodies as opposed to true differences in antigen expression on
equivalent memory CD8+ T cell subset seen between mice and humans. RM effector
CD8+ T cells are characterized phenotypically by the loss in expression of CCR7,
CD62L and CD28, and the gain in expression of CD95 (45, 46) (Figure 1-3). In humans,
effector CD8+ T cells are commonly characterized by loss of CCR7, CD62L and CD27
but do not gain the expression of CD45RO (46). The loss in expression of trafficking
receptors CCR7 and CD62L facilitates exit from SLT and migration to sites of infection
(19, 20). The loss of CD28 co-stimulatory receptor is thought to regulate stimulation and
prevent alternate differentiation fates and the acquisition of CD95, or FAS, to induce Fas
mediated cell death on target cells.
The transcriptional network that establishes effector differentiated CD8+ T cells
in RM and humans is similarly defined. Differentiation of naïve or memory CD8+ T cells
into terminally differentiated effectors or effector memory CD8+ T cells includes high
9

expression levels of the transcription factors T-bet, Blimp1, and Id2 where in the absence
of either of these factors robust effector functions and clearance of viral infections is
severely impaired (28, 47-56). Eomesodermin (Eomes) has been identified in effector
CD8+ T cells but is not exclusively expressed in terminal effectors and is detectable in
central memory CD8+ T cells (47, 49, 54-58). It has also been proposed that Runx3 is
involved in early effector differentiation and essential for early cytolytic functions (59,
60). At the same time, repression of transcription factors Bcl-6, TCF1, and Id3 is
required for full effector differentiation and functions (56, 61-63).
Effectors cells are often referred to as terminal effectors cell as they undergo full
attrition and cell death following clearance of antigen. While this attrition occurs, effector
memory and long-lived central memory cells persist with specificity for the same target
antigen, where central memory CD8+ T cells are believe to persists for a longer duration
than effector memory CD8+ T cells. Currently, the exact sequences that lead to central
memory differentiation are not clear. For example, whether central memory CD8+ T cells
are seeded during the initial exposure to infection and primary activation, or whether they
are differentiated and seeded subsequent to clearance of target antigen or infection
remains undefined (53). Nevertheless, what is clear is the establishment of a long-lived
repertoire of antigen specific CD8+ T cells (central memory) that retain the ability to
differentiate into effector CD8+ T cells upon re-exposure to antigen.
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Chapter 1.2.6 Establishing long-lived CD8+ T cell memory
The memory T cell compartment is composed of effector memory, transitional
memory and central memory subsets. Each serves to retain immunological recognition
and response to foreign antigen following initial exposure as well as functional
responsiveness during re-exposure. Memory CD8+ T cells have the potential to
differentiate into effector CD8+ T cells during recall responses.
The effector memory subset of CD8+ T cells retain some machinery immediately
available to mediate effector functions or differentiate into terminal effector cells. This
machinery includes perforin and granzyme B expression and transcriptional profiles
expressing T-bet, Blimp1 and Id2 to rapidly acquire full effector functions upon reexposure and even during primary exposure (64). At the same time, expression of Bcl6,
ID3 and TCF1 are actively repressed to inhibit central memory cell differentiation. The
longevity of effector memory responses however, is thought to be less than central
memory or transitional memory cells. Effector memory CD8+ T cells in RM are
phenotypically identified by CD95 expression and the absence of CCR7, CD62L and
CD28, which at the same time include terminal effectors (45) (Figure 1-3). In humans,
effector memory CD8+ T cells most critically are defined by the absence of CCR7,
CD62L and CD27, and the expression of CD45RO (46).
Central memory CD8+ T cells passively and actively survey the host for reexposure to antigen (20, 21, 65). True central memory CD8+ T cells are thought to have
the greatest longevity and retained ability to give rise to effector and effector memory T
cells upon re-exposure for many years following primary exposure. However, this
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thought has more recently been challenged following the characterization of stem cell
memory CD8+ T cells (25). Central memory CD8+ T cells are less immunologically and
metabolically active than effector responses and depend on cytokines IL-7 and IL-15 as
opposed to dependence on cognate antigen for their survival as with effector CD8+ T
cells (26, 66). Dependence on homeostatic cytokine signaling affords the possibility of
central memory T cells to persist in the absence of antigen. CD8+ central memory T cells
lack the machinery to carry out effector functions, but maintain the ability to produce
cytokine or inflammatory cytokine production upon exposure to cognate antigen. Thus,
stimulation and production of cytokines is often used as a measure of memory persistence
(10). CD8+ central memory T cells are often identified in RM by the co-expression of
CD28 and CD95, along with CCR7 expression, where CCR7 is important for T cell
migration to SLT where these cells can survey for re-exposure to cognate antigen (45).
In humans, central memory T cells are often identified by CD45RO, CCR7, CD62L and
CD27 expression (46). In both humans and RM, central memory T cells maintain a
similar transcriptional profile including sustained Eomes expression, Fox01, Bcl-6, Tcf1,
Bach2 and the absence of high levels of T-bet and Blimp1 (9, 49, 53, 67-69).
Transitional memory CD8+ T cells appear as an intermediate population between
central and effector memory differentiation CD8+ T cells (69). However, current
proposed models of memory differentiation have not been able to confirm whether or in
which direction, transitional memory CD8+ T cells move and which memory
compartment they sustain if any. In RM, transitional memory CD8+ T cells are identified
by expression of CD28 and CD95 in the absence of CCR7, whereas in humans
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expression of CD45RO and CD27, in the absence of CCR7 and CD62L phenotype the
transitional memory subset (45, 46).
Chapter 1.2.7 Memory CD8+ T cell recirculation, distribution and tissue-resident
memory CD8+ T cells
As discussed previously, central memory T cells survey the host continuously for
a re-encounter with cognate antigen (Figure 1-1). As such, central memory T cells
maintain the expression of receptors that respond to chemokine gradients for recruitment
to SLT (19-21). Thus, many central memory T cells can be found in SLT during
homeostasis (21, 70). However, central memory T cells compose a small fraction of
memory CD8+ T cell in the peripheral blood as compared to the effector memory and
naïve composition (70). These data suggest that central memory T cells actively migrate
throughout the circulatory system and SLT providing full surveillance of the host for
timely responses upon re-exposure.
A more recently described and highly attractive population of memory CD8+ T
cells called tissue resident memory cells (Trm) are tissue residing antigen experienced
memory cells that provide rapid antigen-specific defense upon re-exposure (71-76).
Initial characterization of Trms following antigen priming via vaccination or pathogen
challenge was characterized in epithelial layers of skin and gastrointestinal tract of
challenged mice (77). More recently, Trms have been described to take residence in
primary and secondary lymphoid tissues, such as thymus and lymph nodes (71, 73, 74).
These memory CD8+ T cells have been identified based on the expression of retention
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molecules CD103 and CD69 as well as adhesion molecules such as alpha-4 beta-7 and
other integrins (72, 75, 76). Although, there has been no single immunophenotype that
describes the Trm subset of CD8+ T cells that is constitutively expressed irrespective of
tissue residence. Rather, the anatomical residence where Trms are located appears to
determine the phenotypic profile of these cells. The gene expression profile of Trms from
various anatomical compartments, primarily analyzed in mice, includes effector
molecules (ie. granzyme B) with a partial transcriptional profile of effector memory
CD8+ T cells.
A key feature of Trms includes limited migration and trafficking. Studies using
intra animal anatomically distinct flanks, as well as parabiotic mice, determined that
Trms do not re-circulate but instead take up persistent residence at the site of antigen
encounter (74, 77). More recently, it has been described that upon re-exposure, Trms seed
effector CD8+ T cells at the primary exposure site thus confirming their role as rapid
responder cells (78).
This thesis addresses the distribution of SIV-specific CD8+ T cells in anatomical
compartments harboring viral reservoir during the earliest phase of SIV infection
and during the transition to chronic phase of the infection.

Chapter 1.3 CD8+ T cell effector functions
The importance of CD8+ T cell effector function in clearing pathogen infected or
cancerous self-cells is inarguable. CD8+ T cells use various pathways to mediate cellmediated effector responses including contact dependent and contact independent
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mechanisms that are necessary to execute target cell death or anti-viral immunity (Figure
1-2).
Through primary immunodeficiencies identified in humans, we have
characterized several components of CD8+ T cell effector functions that are indispensible
for clearance of frequently encountered bacteria, viruses and fungi ubiquitous in our
surrounding (79). Additionally, we have seen the importance of T cells in mediating
elimination of cancerous self-cells. This has been highlighted in recent years with
increasing numbers of solid organ transplantation, where normal post-transplantation
protocols include long-term T cell immunosuppression that often lead to the generation of
B cell lymphomas. Similarly, during progressive HIV infection, prior to the advent of
antiretroviral therapy, most patients developed the severely immune compromised state
of acquired immunodeficiency syndrome (AIDS) that frequently co-presented with
lymphomas and sarcomas consequential of CD4+ T cell depletion and full loss of help
for naïve CD8+ T cell activation.
More directly, studies using murine model systems including genetic depletion by
germline knockout, lox-cre inducible deletion, or more recently crisper cas-9 gene
modification, have parsed out the importance of individual and combinatorial CD8+ T
cell effector functions (48, 80). Despite differences between humans, non-human
primates and mice, murine model systems have paved many avenues for better
understanding human CD8+ T cell biology and methods for improving and modifying
effector CD8+ T cell functions in vivo.
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Chapter 1.3.1 Granule-mediated cytolysis
The most studied and well-understood pathway of cell-cell contact dependent
induction of target cell killing is granule-mediated cytolysis. This mechanism is rapid and
target cell directed using antigen-MHC complex recognition specificity, and generally
sustained for serial killing capacity. There are two critical components to granulemediated cytolysis including a pore forming component, typically perforin, as well as a
protease that includes several granzyme family members. Both factors are necessary to
mediate the induction of apoptosis in target cells that signals through caspase dependent
and independent routes (4). As mentioned, the induction of granule-mediated cytolysis is
rapid and is known to be critical for clearance and control of lymphocytic
choriomeningitis virus (LCMV), toxoplasma, vesicular stomatitis virus and listeria
infections in mice (4, 81). In the absence of granule-mediated cytolytic factors, even
single component deficiencies in mice, uncontrollable pathogen burden and even death of
infected mice often occurs (81, 82). Per these studies, it has been determined that both
factors together are necessary for successful granule-mediated cytolysis. The
transcriptional program that drives cytolytic effector responses is discussed below in
Chapter 1.4. Recently, the importance of cytolytic effector mechanisms has been
discussed in the context of human chronic viral infections including HIV, HCV, HBV
and EBV (83-87). Infected subjects, who naturally control these viral infections without
medical intervention, maintain persistent elevated levels of granzymes and perforin over
those with progressive disease. As such, many studies in chronic viral infection and
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cancer have focused on understanding the precise evolution of CD8+ T cell effector
responses that function using granule-mediated cytolysis.
This thesis addresses the evolution of perforin and granzyme B cytolytic CD8+ T
cells responses in various anatomical compartments during early SIV infection in
RM.
Chapter 1.3.2 Fas-Fas ligand induced cytolysis
Contact dependent CD8+ T cell effector functions include CD95-CD95L or FasFasL engagement. This ligation and downstream signaling can induce target cell death
through caspase-dependant and independent mechanisms (4, 88). Not only has Fas-FasL
signaling been noted as a critical mechanism in clearing altered-self cells, such as
cancerous or infected, it has also been shown to have critical functions in immune
homeostasis and modulation of autoreactive cells (88, 89). Most notably, in the lpr, Fasdeficient mouse, high levels of lymphocyte proliferation and auto antibodies develop
(90).
Chapter 1.3.3 Tumor necrosis factor induced cytolysis
In addition to serving as a cytokine for anti-viral alarm and pro-inflammatory
response by innate and adaptive immune cells, tumor necrosis factor (TNF) is involved in
induction of apoptosis in virally infected and cancerous cells (91). TNF is one of the
earliest cytokines produced by memory CD8+ T cells upon primary and recall responses
following exposure to cognate antigen.
17

Chapter 1.3.4 Non-cytolytic effector functions
Non-cytolytic or non-apoptotic CD8+ T cell effector mechanisms function
through release of anti-viral factors, including beta defensins and an unclassified cell
anti-viral factor (CAF) (8, 80, 92). Beta defensins include Mip1α/β as well as RANTES.
These factors have been identified to inhibit HIV/SIV viral entry via competition for
CCR5 HIV/SIV co-receptor binding and therefore do not induce cytolytic effects on
infected cells (6). On the other hand, CAF released from CD8+ T cells is known to be
more directly involved in control of HIV/SIV replication in a unique contact independent
fashion (93, 94). However, the mechanisms that CAF uses to mediate suppression of viral
replication in virus infected cells awaits further validation.
The interplay between cytolytic and non-cytolytic CD8+ T cell effector functions
have been evaluated by many groups and in the context of various pathogenic infections
and in anti-tumor studies (95). It remains debated however, the level of contribution each
of these components makes in driving effector functions in the host at any given time (87,
96). For example, during chronic HIV/SIV infection there is evidence that both cytolytic
and non-cytolytic CD8+ T cell functions may be involved in establishing and maintaining
control of viremia, however to what extent each contributes is left for further
investigation (87, 97, 98).

Chapter 1.4 Transcriptional regulation of CD8+ T cell effector program
The induction of the effector CD8+ T cell program requires a complex network of
input signals and translation of those signals to induce expression of the proper
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transcription factors. Although the evolution of effector CD8+ T cell programming
continues to unveil layers of transcriptional networks including cooperative regulation
and opposing repression, the currently understood balance of the necessary network relies
heavily on a few key transcription factors. The master regulatory factors required for
establishing the optimal effector program include T-bet, Blimp1 and Id2 (99, 100).
Genetic deletion or haploinsufficiency of either of these key transcription factors severely
impairs CD8+ T cell effector differentiation and functions, and consequently results in
uncontrolled viremia and loss of anti-tumor functions (47-49, 52, 53, 55, 56, 67, 69, 101104).
Several other well characterized transcription factors are known to play a role in
the effector CD8+ T cell program that function in a context dependent manner and rely
on the presence of and regulation by master regulatory factors. These include Eomes,
Runx3 and more recently characterized Zeb2 (49, 53, 60, 102, 105, 106). In addition, the
more upstream factor Notch has been described in driving effector memory CD8+ T cell
fate (107, 108). It is important to keep in mind that Notch activation is induced following
extracellular ligand binding and cleavage for translocation to the nucleus, highlighting
exogenous regulation of effector functions. Moreover, these transcription factors are
critical components of the hallmark transcriptional network that has been decoded to
date, although none appears to be as critical as the master transcription factors discussed
above.
While the discussed transcription factors are important for turning on the effector
memory CD8+ T cell program, there are several factors that must be repressed to drive
19

differentiation and maintenance of effector cell functions. Broadly across cell
differentiation and development, the phenomenon of active repression of alternate fates
has repeatedly been described. During effector CD8+ T cell differentiation, active
repression of transcription factors Bcl-6, ID3, Tcf1 and Foxo1 are in place (62). Bcl-6 is
known to compete with Blimp1 and Id2 in effector cells, and with T-bet in effector and
memory T cells (52, 55, 63, 69, 100, 109). Importantly, several studies have characterized
a master regulatory role for the transcription factor Foxo1 in driving the expression of
central memory differentiation factors and actively repressing the effector memory
program (58, 61, 68, 69). Nevertheless, the regulation and maintenance of a unique
transcriptional profile and network of factors is essential for effector CD8+ T cell
differentiation and the ultimate desired effector function and in establishing long-lived
immunological memory.
This thesis characterizes expression of the transcription factor T-bet in SIV-specific
CD8+ T cells during acute phase SIV of infection to evaluate proper transcriptional
regulation of the cytolytic effector program.

Chapter 1.5 CD8+ T cell function in chronic viral infections
While CD8+ T cells can recognize an infinite number of antigens and even
generate a memory response to those antigens for the duration of the life of the host,
many viruses evade immune detection and/or clearance and subsequently establish
deleterious chronic infections. Such viral infections include HIV, Hepatitis C and B
(HCV and HBV, respectively), Epstein-Barr virus (EBV), and HPV driving cutaneous,
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hematologic, hepatic, and eurogenital and head and neck malignancies (110, 111). The
inability to clear these viral infections is at least in part due to insufficient function of
CD8+ T cell effector responses.
Chapter 1.5.1 Animal models for understanding CD8+ T cells functions during
chronic viral infections
Our understanding of the importance of CD8+ T cells in control of viral infection
has been achieved through the use of various animal models including mice and nonhuman primates. Importantly, these models have afforded us the opportunity to identify
CD8+ T cell correlates of control with deeper rigor than using patient derived T cells
alone. Studies using the LCMV infection model in mice have done an exceptional job at
teasing apart the formation of efficient and insufficient effector and memory CD8+ T cell
responses following exposure to chronic LCMV. In an effort to more closely mirror the
induction of chronic HIV infection in humans, the SIV infection model in RM has been
instrumental in identifying the functions and dysfunctions of CD8+ T cells that lead to
HIV/AIDS and SIV/SAIDS that are similarly applicable in understanding persistence of
other human chronic viral infections.
The importance of CD8+ T cells in control of viral infections has been
demonstrated in their absence by way of antibody-mediated depletion or β2microglobulin
knockout- MHC Class I deficiency in murine models (112-114). In these CD8+ T cell
deficient models, viral infections are unmanaged and remain high following initial
exposure in absence of CD8+ T cells or subsequent to CD8+ T cell depletion during
21

established infection consequently leading to premature disease-mediated pathology,
progression and ultimately death of the host. Additionally, the induction of viral escape
mutations to CD8+ T cell recognized epitopes has highlighted the magnitude and success
of CD8+ T cell immune pressure on virus to select against viral variants expressing those
recognized epitopes (115-119). Moreover, animal models have provided an invaluable
tool to define and demonstrate the critical importance of CD8+ T cells in clearing or
controlling infection.
With particular interest to this thesis, the use of the RM SIV infection model has
fostered our understanding of the importance of CD8+ T cell in resolving acute phase
viremia, or set point viremia. More recently, studies have described the importance of
maintaining CD8+ T cells within the SLT for containment of virus in lymphoid follicles
during acute and chronic phases of SIV infection (112, 113, 120-122). Along these lines,
Cartwirght et al. recently showed the requirement for CD8+ T cells in the full
suppression of SIV viremia, even under antiretroviral therapy (123).
This thesis describes work implementing the RM SIV infection model to
characterize the evolution of CD8+ T cells in critical anatomical compartments
during acute and progressive SIV infection.
Chapter 1.5.2 CD8+ T cell correlates of viral control
The presence of CD8+ T cells alone is insufficient for mediating clearance or
adequate control of viral infections. CD8+ T cell correlates of viral control begin with
optimal exposure to cognate antigen via APCs, TCR signaling, co-stimulation and
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sufficient CD4+ T cell help. Not surprisingly, associations between MHC I alleles and
the ability to control HIV/SIV infection are well described and are preferentially
expressed in a population of infected subjects, elite controllers, who maintain control of
viremia without therapeutic intervention (124, 125). For this reason, it is likely that
optimal antigen recognition and TCR signaling occur with these particular MHC alleles
that allow development of the most optimal CD8+ T cell effector responses (126). These
initial steps are foundational for the induction of the effector memory program where
high levels of master regulatory factors such as T-bet and Blimp1 are induced and
maintained throughout the peak of infection until pathogen clearance (47, 85, 121, 127129). Early loss of high levels of T-bet are associated with the induction of poor effector
functions, described as immune exhaustion (47, 128, 130). Equally as important,
expression of cytolytic factors such as perforin and granzymes by CD8+ T cells are
essential for mediating clearance of target cells and their expression levels correlate with
viral control and clearance (83, 85, 86, 127, 131, 132). Each of these CD8+ T cell
correlates of control contributes to establishment and maintenance of functional CD8+ T
cell memory.
Chapter 1.5.3 CD8+ T cell exhaustion in chronic viral infection
Our best understanding and explanation of viral persistence of chronic viral
infection is the development of progressively dysfunctional CD8+ T cell responses,
otherwise known as CD8+ T cell exhaustion. We are currently impressed by how early
during infection CD8+ T cell dysregulation begins, immune exhaustion is established and
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consequential persistent viral infection is established. In the murine model of chronic
viral infection with LCMV clone 13, the kinetics of virus-specific CD8+ T cell
dysregulation has been evaluated and implicated to develop as early as 8 days post
infection (127, 128). From this model, we have identified and characterized exhausted
CD8+ T cells by loss in optimal transcriptional regulation by T-bet and Blimp1, and
progressive acquisition of the inhibitory receptor expression profile most notably of PD1, 2B4, CD160, and Lag3 among others (47, 127, 128, 133-138). At the same time,
exhausted CD8+ T cells progressively lose cytokine polyfunctionality in a hierarchical
fashion, beginning with IL-2 followed by TNF and lastly IFNγ (137, 139). Importantly,
these characteristic developments of CD8+ T cells during chronic LCMV infection have
been nearly directly translatable to the phenomenon of immune exhaustion in humans and
non-human primates during viral infections and cancer.
Induction of immune exhaustion during human chronic viral infections has been
less well characterize due to complications in precisely identifying primary infection and
time to diagnosis, as well as tissue sample availability in human subjects that is typically
restricted to peripheral blood, a tissue that may not be an appropriate sample of
lymphocytes in close proximity to viral reservoir. However, characterization of poorly
functional virus-specific CD8+ T cells during chronic viral infections in humans has been
described (83, 85, 86, 130, 132, 140). A recent study from our lab identified acute phase
dysregulation of T-bet expression in HIV-specific CD8+ T cells following peak HIV
viremia that persisted into chronic phase of infection and was associated with a loss in
cytolytic perforin expression as infection progressed (130). Moreover, the consequential
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induction of CD8+ T cell dysregulation during the acute phase of chronic viral infections
demands continued attention for improved clinical outcomes.

Chapter 1.6 HIV/SIV pathogenesis and the immune system
Infection with HIV in humans or SIV in macaques poses genuinely unique
challenges to the immune system in the feasibility of managing the virus. Most
importantly, the CD4+ T helper cells that HIV/SIV infects are a backbone of the adaptive
immune system (Discussed in Chapter 1.1.2). For example, immunological memory
functions that are highly dependent on CD4+ T helper cells are progressively lost during
infection. Moreover, infected hosts do not succumb to the viral infection itself but rather
the consequential immunopathologies associated with the infection that ultimately
establish the immune deficient state of AIDS.
During primary exposure, antiviral responses including high levels of immune
activation are initiated and persist. In an antiviral effort, massive pro-inflammatory
responses driven by type I interferons and immune activation are initiated that
paradoxically feed a detrimental cycle of inflammation and further susceptibility to
infection. Upon activation, CD4+ T cells express the chemokine receptor CCR5, the
canonical co-receptor for HIV/SIV viral entry, and become susceptible to infection. In
most cases of infection, the immune system manages to establish some balance between
immune activation and viral replication where a viral set point is achieved and viremia is
maintained at the set point level for a period of time until the immune system fails to
maintain this balance.
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Chapter 1.6.1 Loss of CD4+ T cell help impacts new immunological memory
formation during HIV/SIV infection
The persistent immune activation and consequential depletion of infected CD4+ T
helper cells following HIV/SIV infection have cumulative consequences for generating
new adaptive immune responses. CD4+ T helper cells provide the essential signals for
selection, programming and expansion of memory T and B cell responses. While the
availability of helper functions dampen throughout infection, the potential breadth of
memory CD8+ T and B cell repertoires becomes compromised. This impairment of
helper functions impacts not only new response to HIV/SIV, but also impacts responses
to persistent co-infections such as cytomegalovirus virus and EBV, or new encountered
pathogens and altered-self proteins. For example, patients with chronic HIV infection
have reduced breadth of memory T and B cells responses to flu virus following flu
vaccination and increase presentations of cancers driven by EBV, HCV, HBV, human T
lymphocytic virus-1, and Kaposi’s sarcoma herpes virus (110, 111). Humoral mediated
responses are known to contribute to the control of HIV/SIV viremia. Therefore, loss of
helper functions to expand the repertoire of antibodies against HIV/SIV are also likely
impaired by progressive CD4+ T cell depletion.
Chapter 1.6.2 Immunopathologies associated with HIV/SIV infection
While depletion of CD4+ T cells is known to be the most deleterious consequence
of HIV/SIV infection, additional immunopathologies are irreversibly established even
following initiation of antiretroviral treatment. Rapid and sustained depletion of CD4+ T
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cells from the gut mucosa compromises the integrity of the local mucosal barrier and has
been implicated in fostering chronic immune activation via bacterial translocation from
the gut lumen to the circulation (141). For undefined reasons that may be associated with
trafficking, CD4+ T cells are not replenished in the gut mucosa, even during
antiretroviral treatment (142). Equally as important, massive immune activation triggers
local deposition of fibrous material at sites of infection including SLT and gut mucosa
(33, 143). While in most infections this deposition can facilitate containment of the
pathogen, collagen deposition to lymphoid tissues and gut mucosa exacerbates impaired
immune memory formation and normal barrier functions of the gut mucosa (144).
Specifically, deposition of collagen in SLT disrupts the intricate and purposefully
designed architecture that is essential for orchestrating immune cell localization, contact
and ultimately formation of lymphoid follicles and germinal centers (144).
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Chapter 1.7 Figures

Figure 1-1 Classical model of CD8+ T cell memory differentiation and tissue
distribution following infection
Encounter of CD8+ T cells with antigen presented on APC in SLT and subsequent CD4+
T cell help in activation and memory differentiation prior to egress of the CD8+ T cell
from lymphoid tissue. High accumulation of effector memory CD8+ T cells occurs
within the peripheral blood circulation, as compared to central memory and transitional
memory responses. Effector and effector memory responses reach infected tissue, where
infected cells are cleared by CD8+ T cell effector functions. Following clearance of
infection, tissue resident memory CD8+ T cells can be detected at the sites of cleared
infection. Central memory responses mediate systemic surveillance of SLT for reexposure to antigen by way of high endothelial venules, and peripheral blood circulation.
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Figure 1-2 CD8+ T cell effector functions
Cytolytic and non-cytolytic CD8+ T cell effector functions used to reduce viral burden
during infection. Cytolytic effector functions deliver cytotoxic granules directly to target
cells in a contact-dependent manner that are driven via TCR recognition of peptide on
MHC I. Non-cytolytic functions secrete antiviral factors in a contact-independent manner
that block viral entry and directly suppress viral replication in infected cells.
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Figure 1-3 Gating strategy for CD8+ T cell memory subset identification
A) Identification of CD8+ T cells through fluorescence cytometry staining for antigens
expressed by CD8+ T cells. Gating strategy for stained lymphocytes to isolate CD8+ T
cells and subsequent identification of naïve and memory CD8+ T cell subsets.
Differential expression of additional antigens of interest can be identified in memory
CD8+ T cell subsets. B) CD8+ T cell memory subsets in RM are identified by the
indicated combinatorial staining of CD28, CD95 and CCR7.
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Chapter 2: Collapse of cytolytic potential in SIV-specific
CD8+ T cells during acute SIV infection in Rhesus Macaques
Chapter 2.1 Abstract
Poor maintenance of cytotoxic factor expression among HIV-specific CD8+ T
cells, in part caused by dysregulated expression of the transcription factor T-bet, is
associated with HIV disease progression. However, the precise evolution and context in
which CD8+ T cell cytotoxic functions become dysregulated in HIV infection remain
unclear. Using the RM SIV infection model, we evaluated the kinetics of SIV-specific
CD8+ T cell cytolytic factor expression in peripheral blood, lymph node (LN), spleen,
and gut mucosa from early acute infection through chronic infection. We identified rapid
acquisition of perforin and granzyme B expression in SIV-specific CD8+ T cells in
blood, SLTs and gut mucosa that collapsed rapidly during the transition to chronic
infection. The evolution of this expression profile was linked to low expression of T-bet
and occurred independent of epitope specificity, viral escape patterns and tissue origin.
Importantly, during acute infection SIV-specific CD8+ T cells that maintained T-bet
expression retained the ability to express granzyme B after stimulation, but this
relationship was lost in chronic infection. Together, these data demonstrate the loss of
cytolytic machinery in SIV-specific CD8+ T cells in blood and at tissue sites of viral
reservoir and active replication during the transition from acute to chronic infection. This
phenomenon occurs despite persistent high levels of viremia suggesting that an inability
to maintain properly regulated cytotoxic T cell responses in all tissue sites enables

31

HIV/SIV to avoid immune clearance, establish persistent viral reservoirs in lymphoid
tissues and gut mucosa, and lead ultimately to immunopathogenesis and death.

Chapter 2.2 Introduction
While it is clear that CD8+ T cells are a critical component of the host immune
response to HIV and SIV control, these cells only rarely fully control virus replication
(i.e., elite controllers) (145-147). The reasons why CD8+ T cells do not control HIV/SIV
replication in the majority of infected individuals remain unclear. Seminal work directly
identifying the importance of CD8+ T cells in partial containment of viremia was
performed in SIV infected RM, whereby depletion of CD8+ T cells consistently resulted
in significant increases in viremia and accelerated disease progression (112, 113). In
addition, in vivo viral evolution studies revealed the emergence of escape mutants for the
most common immunodominant CD8+ T cell viral epitopes of SIV, thus demonstrating a
significant level of immune pressure exerted on the virus by CD8+ T cells (116, 118).
More recently, CD8+ T cell depletion studies in elite controller SIV infected RM
indicated the requirement of CD8+ T cell persistence in LN and spleen to maintain
control of plasma viremia and productively infected CD4+ T cells in these tissues (120,
122).
Several effector mechanisms have been proposed to explain how CD8+ T cells
mediate viral control, including cytolytic and non-cytolytic processes (7, 97, 98).
Granule-mediated cytolysis is a rapid and powerful effector response used by cytotoxic
CD8+ T lymphocytes (CTL) to clear target cells in an antigen-specific manner (4, 5).
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This process includes two necessary factors, a pore forming component, perforin, which
enables entry of a protease, most often granzyme B, to induce programmed cell death
through both caspase-dependent and caspase-independent induction of apoptosis (4). The
induction and maintenance of granule-mediated cytolysis, including the expression of
perforin and granzyme B has been shown to be in part mediated by the transcription
factor T-bet, where in its absence CD8+ T cell effector functions are significantly
reduced (47, 48, 85, 102, 130, 148, 149). Previous studies have shown that the
maintenance of CD8+ T cell killing capacity is a key factor in control of HIV infection,
as measured by granzyme B and perforin expression and expression levels of T-bet (83,
85, 86, 131, 132). These studies highlight the relationship of low levels of viremia in HIV
elite controllers with the presence of robust T-bet controlled CTL killing potential by
HIV-specific CD8+ T cells that is present through chronic phase of infection. This is
further supported by a recent study from our group describing the evolution of HIVspecific CD8+ CTL during acute infection and identified the loss of T-bet and concurrent
declining perforin expression as key markers of the transition from acute to the chronic
phase of HIV infection (130). Virus-specific CD8+ T cell non-cytolytic mechanisms
mediated by β-chemokines, α-defensins, and the unclassified suppressive factor, CAF,
have been evaluated albeit less extensively than cytolytic mechanisms during HIV/SIV
infection (6, 93, 94, 150). Both Mip-1α and α-defensin productions by CD8+ T cells are
positively correlated with control of HIV viremia in elite controller subjects, although
their role is likely more involved in blocking receptor binding and subsequent infection
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(150-152). Nevertheless, these factors are thought to contribute to control of viremia
without elimination of infected cells (97, 98).
Secondary lymphoid tissues and gut mucosa are key sites of HIV/SIV replication
and reservoirs during the acute and chronic phases of infection (153-156). In particular,
follicular CD4+ T helper cells harbor high levels of integrated provirus and are major
contributors to both ongoing viral replication and virus rebound observed following
interruption of antiretroviral therapy (153, 154). Studies detecting virus-specific CD8+ T
cells from SLT and gut mucosa have been focused primarily on the chronic phase of
infection with few studies investigating the early acute phase (155, 157-160). As such, it
remains unclear to what degree virus-specific CD8+ T cells in these compartments
possess cytolytic function when the reservoir is first seeded and subsequently maintained.
These studies underscore the need to evaluate virus-specific CD8+ CTL potential in SLT
and gut mucosa in the earliest detectable responses in acute infection, as well as those
present during chronic infection.
In the current study we sought to address these issues through sequential necropsy
conducted during the acute phase of infection in SIV infected macaques to longitudinally
dissect the evolution of cytolytic CD8+ T cell function in blood and at relevant sites of
viral replication, including SLT and gut. To this end, we infected Mamu A*01-positive
RM with SIVmac251 and longitudinally monitored the CD8+ T cell responses to two
immunodominant epitopes, Tat-TL8 and Gag-CM9, for their acquisition and modulation
of cytolytic factors granzyme B and perforin in blood, spleen, LN and gut mucosa
through the earliest stages of acute infection and up to chronic infection. We found that
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the initial high expression of cytolytic factors was remarkably short-lived, and collapsed
rapidly during late acute infection in nearly all animals. This phenomenon resulted in low
levels of cytolytic SIV-specific CD8+ T cell responses during the chronic phase of
infection despite high plasma viremia. Notably, SIV-specific CD8+ T cells in LN
consistently expressed lower levels of perforin, and granzyme B as well as T-bet
compared to their peripheral blood counterparts. These findings demonstrate the rapid
collapse of a dominant cytolytic profile among SIV-specific CD8+ T cells during acute
SIV infection in all tissue compartments, most importantly in SLT where active seeding
of SIV reservoir and viral replication is initiated and persists during chronic infection.

Chapter 2.3 Results
Induction and resolution of cytolytic SIV-specific CD8+ T cell responses during
acute SIV infection
To define the acute kinetics of the CD8+ T cell response in SIV infection, we
infected n=18 RM with 500TCID50 SIVmac251 iv and performed a timed tissue collection
and necropsy protocol through chronic infection. We collected blood, spleen, mesenteric
lymph nodes (mLN), superficial lymph nodes (sLN), and rectal biopsies (RB) at the
indicated time points pre- and post-infection (Figure 2-1a and Figure 2-2a). We infected
all animals with a high dose of SIVmac251 virus in order to synchronize the infection and
peak viremia. As shown in Figure 2-2b, the kinetics of viremia were uniform and
reproducible in all animals. As expected, viremia in these animals peaked between 10 and
13dpi (Range: 1.5e7 - 1.06e8), and high viral loads persisted until necropsy. No animals
35

showed signs of controlled viremia during the transition from acute to chronic phase of
infection. As expected, during acute infection, absolute CD4+ T cells counts decreased
rapidly and remained low in all animals (Figure 2-2c), and the percentage of CD4+ T
cells in the gut mucosa declined precipitously within the first 5dpi, and remained very
low in all animals (Figure 2-2d)(161).
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Figure 2-1 Evolution of CTL in peripheral blood during acute SIV infection
A) Experimental design including SIV infection, tissue and blood sample collection (TC),
and necropsy (Nec) time points. B) Flow cytometry plots of Tat-TL8 and Gag-CM9
Mamu A*01 tetramer staining in CD8+ T cells at pre-infection, acute, and chronic
infection from a representative animal. Frequencies of single positive tetramer+ events
are shown. C) The frequency of TL8 and CM9 tetramer+ SIV-specific CD8+ T cells in
peripheral blood CD8+ T cells throughout infection. D) Flow cytometry plots of perforin
and granzyme B expression in TL8 and CM9 tetramer+ SIV-specific CD8+ T cells (TL8
tetramer+ in red, and CM9 tetramer+ in blue) overlaid on total CD8+ T cells (black) at
pre-infection, 13dpi, and 90dpi from representative animals. Frequencies of gated
populations are shown of TL8 or CM9 tetramer+ cells. E) The frequency of perforin and
granzyme B (Perf+GrzB+) co-expression among TL8 or CM9 tetramer+ SIV-specific
CD8+ T cells throughout infection. F) The median fluorescence intensity (MFI) of
perforin and granzyme B in Perf+GrzB+, tetramer+ SIV-specific CD8+ T cells
throughout infection. Lines connecting data points represent longitudinally collected data
from individual animals.
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Figure 2-2 Established infection and sample collection schedule
A) Detailed tissue collection schedule including the number of unique samples collected
at each indicated time point. B) SIV blood plasma viral loads (RNA copies/mL) at the
indicated time points post-infection from each animal. Lines connecting data points
reflect longitudinal monitoring of individual animals. C) Absolute CD4+ T cell counts
per mL of whole blood at the indicated time points from individual animals. Mean ± SD
of data collected at each time point is plotted as a line along with individual data points.
D) CD4+ T cell counts as a proportion of total CD3+ T lymphocytes from rectal biopsies
(RB) at the indicated time points from individual animals. Mean ± SD of data collected at
each time point is plotted as a line along with individual data points.

38

To assess the induction of cytolytic SIV-specific CD8+ T cell responses, we first
evaluated the responses to the immunodominant Mamu A*01 restricted epitopes Tat-TL8
and Gag-CM9 in peripheral blood. As shown in Figure 2-1b and Figure 2-1c, CD8+ T
cells specific for TL8 or CM9 epitopes peaked at 13dpi, followed by contraction into the
chronic phase of infection as previously been described (116). We next evaluated the
expression of the cytolytic proteins perforin and granzyme B by SIV-specific CD8+ T
cells. We found high co-expression of both molecules in Tat-TL8 and Gag-CM9 specific
CD8+ T cells in blood that peaked at 13dpi, as shown in Figure 2-1d and Figure 2-1e.
This cytolytic profile was short-lived however, with less than 50% on average of SIVspecific CD8+ T cells maintaining perforin and granzyme B co-expression beyond 21dpi.
The collapse in co-expression of perforin and granzyme B occurred independent of
epitope specificity as seen in both TL8 and CM9-specific responses (Figure 2-1e).
Perforin and granzyme B expression on a per-cell basis peaked at 13dpi of the acute
phase and similarly decreased as animals progressed into chronic infection (Figure 2-1f).
Previous studies documented the rapid and complete escape of the Tat-TL8
epitope (TTPESANL) during acute infection (116). We therefore sought to confirm this
finding as it relates to potential pressure mediated by cytolytic SIV-specific CD8+ T
cells. Escape of the Tat-TL8 epitope, present in more than 50% of SIVmac251 inoculum
virus (Figure 2-3a), occurred during the peak cytolytic TL8-specific response as seen in
Figure 2-3b. However, the Gag-CM9 epitope did not escape despite similar CD8+ T cell
mediate cytotoxic pressure, likely due to fitness constraints on this epitope as discussed
previously (Figure 2-3b) (115). Together these data show that the initial circulating CD8+
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T cell responses to SIV infection have high expression of cytolytic molecules that is
rapidly lost as infection transitions into the chronic phase.
Rapid loss of cytolytic CD8+ T cells from secondary lymphoid tissues
To assess the evolution of cytolytic SIV-specific CD8+ T cells at relevant sites of
viral replication and reservoir, we next examined Tat-TL8 and Gag-CM9 specific CD8+
T cell responses in LN, spleen and gut mucosa tissue throughout acute infection. Tat-TL8
and Gag-CM9-specific CD8+ T cell responses were readily detectable in LN, spleen and
gut mucosa as previously described (Figure 2-4) (162, 163), peaking at 13dpi in all
measured tissues, and underwent contraction in all tissues while SIV infection transitions
into its chronic phase (Figure 2-5a).
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Figure 2-3 Sequence evolution of Tat-TL8 and Gag-CM9 epitopes
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mLN, spleen and RB at the indicated time points from representative animals.
Frequencies of gated events are shown.
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Figure 2-5 Evolution of CTL in blood, SLT and gut mucosa during acute SIV
infection
A) The frequencies of TL8 and CM9 tetramer+ SIV-specific CD8+ T cells among CD8+
T cells in mLN, sLN, spleen, gut mucosa and blood at the indicated time points. B) Flow
cytometry plots of perforin and granzyme B expression in TL8 and CM9 tetramer+ SIVspecific CD8+ T cells (TL8 tetramer+ in red, and CM9 tetramer+ in blue) overlaid on
total CD8+ T cells (black) in blood, sLN, mLN and spleen at pre- infection, 13dpi, and
90dpi from representative animals. Frequencies of gated populations are shown of TL8 or
CM9 tetramer+ cells. C) The frequencies of Perf+GrzB+ co-expression in TL8 and CM9
tetramer+ SIV-specific CD8+ T cells from blood, sLN, mLN and spleen at the indicated
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Figure 2-5 continued: time points throughout infection; Linear regression ANOVA of
samples collected between 13dpi and 90dpi. D) Kinetics of perforin median fluorescence
intensity (MFI) in Perf+GrzB+ TL8 and CM9 tetramer+ SIV-specific CD8+ T cells at the
indicated time points throughout infection; Linear regression ANOVA of samples
collected between 13dpi and 90dpi. E) Perforin MFI in Perf+GrzB+ tetramer+ cells in
sLN and blood at 13dpi or 90dpi; Paired, one-tailed Student’s t-test; 13dpi (n=12 pairs) or
90dpi (n=3 pairs). Lines connecting data points represent longitudinally collected data
from sLN and blood of individual animals. * p<0.05 , ** p<0.01. No significant
differences “ns”.
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Co-expression of perforin and granzyme B was detectable in SIV-specific CD8+
T cells in sLN, mLN, and spleen (Fig2-5b) and peaked at 13dpi in all measured tissues
(Fig2-5c). SIV-specific CD8+ T cells in gut mucosa also showed very high granzyme B
expression at peak viremia in nearly all animals (perforin not measured; Fig2-6a and 26b). However, following peak responses, we observed a rapid loss of perforin and
granzyme B co-expression within TL8 and CM9-specific CD8+ T cells in 8 out of 9
animals by 41dpi, shown in Fig2-5c. We also observed declining granzyme B expression
in SIV-specific CD8+ T cells in gut mucosa as animals transitioned to chronic infection
(Fig2-6b).
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Figure 2-6 Granzyme B and T-bet expression are detectable in SIV-specific CD8+ T
cells from gut mucosa during acute SIV infection
A) Flow cytometry plots of granzyme B and T-bet expression in TL8 and CM9-specific
CD8+ T cells (Tat-TL8 tetramer+ CD8+ T cells in red and Gag-CM9 tetramer+ responses
blue) in total CD8+ T cells (black) from RB samples pre-infection, at 13dpi, and 41dpi
(late acute) from a representative animal. Frequencies of gated events among tetramer+
events are shown. B) Kinetics of granzyme B expression in tetramer+ SIV-specific CD8+
T cells from RB throughout acute infection. Lines connecting data points represent
longitudinally collected data from individual animals.
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We next performed a quantitative analysis of the expression levels of perforin and
granzyme B by median fluorescence intensity (MFI) in the subset of SIV-specific CD8+
T cells co-expressing perforin and granzyme B (Figure 2-5d, and Figure 2-7). Similar to
blood (Figure 2-1f), perforin MFI peaked at 13dpi in SIV-specific CD8+ T cells in sLN
but showed limited expression throughout infection in mLN and spleen (Figure 2-5d).
Perforin expression was reduced in SIV-specific CD8+ T cells from sLN compared to
blood at peak response and in TL8-specific CD8+ T cells during chronic infection
(Figure 2-5e). Lower perforin expression levels were detected in CM9-specific CD8+ T
cells in 2 out of 3 animals at chronic infection. Granzyme B within SIV-specific CD8+ T
cells largely mirrored the expression level of perforin over time, peaking at 13dpi
followed by a decline in expression levels during the transition to chronic infection
(Figure 2-7). However, unlike perforin expression, we did not detect a significant
difference in granzyme B expression levels between blood and matched sLN during acute
or chronic phase of infection (data not shown). Collectively, these data indicate shortlived cytolytic profiles in SIV-specific CD8+ T cell responses from the blood, SLT and
gut mucosa during acute infection.
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Figure 2-7 Kinetics of granzyme B MFI in cytolytic tetramer+ SIV-specific CD8+ T
cells during acute infection
Median fluorescence intensity (MFI) of granzyme B in Perf+GrzB+ TL8 and CM9
Tetramer+ SIV-specific CD8+ T cells in blood, sLN, mLN, and spleen at the indicated
throughout infection. Linear regression ANOVA for samples collected between 13dpi
and 90dpi. Lines connecting data points represent longitudinally collected data from sLN
and blood of individual animals. No significant differences “ns”.
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Progressive loss of T-bet expression within SIV-specific CD8+ T cells in acute SIV
infection
To define potential mechanisms underlying the loss of cytolytic molecule
expression, we assessed T-bet expression in tetramer+ SIV-specific CD8+ T cells from
acute through chronic infection. T-bet was initially expressed by a subset of SIV-specific
CD8+ T cells in blood, LN, and spleen (Figure 2-8a) and gut mucosa (Figure 2-6a)
during acute infection. T-bet expression in SIV-specific CD8+ T cells peaked at 13dpi in
all tissues except the spleen, where peak T-bet expression was more varied (Figure 2-8b).
Subsequent to peak expression, T-bet expression in TL8-specific CD8+ T cells in LN and
blood declined precipitously following peak viremia, in a similar fashion as cytolytic
molecules in SIV-specific CD8+ T cells declined (Figure 2-5c). Similar, though not as
dramatic, losses of T-bet were also observed in CM9-specific CD8+ T cells following
peak viremia. We also compared the proportion of T-bet+ SIV-specific CD8+ T cell
responses between sLN and blood, and found no significant difference at 13dpi or 90dpi
(data not shown).
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Figure 2-8 Kinetics of T-bet expression in SIV-specific CTL during acute SIV
infection
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Figure 2-8 continued: A) Flow cytometry plots of T-bet expression in TL8 and CM9
tetramer+ SIV-specific CD8+ T cells (TL8 tetramer+ in red, and CM9 tetramer+ in blue)
overlaid on total CD8+ T cells (black) in blood, sLN, mLN, and spleen at the indicated
time points from representative animals. Frequencies of T-bet+ tetramer+ events are
shown. B) The frequencies of T-bet expression among tetramer+ SIV-specific CD8+ T
cells in blood, sLN, mLN, spleen and gut mucosa at the indicated time points. C)
Frequencies of T-bet expression in cytolytic (Perf+GrzB+) SIV-specific CD8+ T cells in
blood, sLN, mLN and spleen throughout infection. Linear regression ANOVA for
samples collected between 13dpi and 90dpi. Lines connecting data points represent
longitudinally collected data from sLN and blood of individual animals. No significant
differences “ns”.
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We further examined T-bet expression within SIV-specific CD8+ T cells that coexpressed perforin and granzyme B. T-bet expression was higher in Perf+GrzB+ SIVspecific CD8+ T cells in all sites during the acute period except in spleen, where T-bet
expression varied (Figure 2-8c). Following the acute period, T-bet expression within
Perf+GrzB+ SIV-specific CD8+ T cells declined as infection progressed, with the
strongest effect occurring in TL8-specific responses. At 90dpi, similarly low levels of Tbet were detected between the different antigen specificities and tissues examined.
Together these data show that SIV-specific CD8+ T cells rapidly lose expression of the
master transcription factor T-bet that is likely required to sustain optimal cytolytic
responses within CD8+ T cells during the course of infection.
Partial loss of the cytolytic profile in responding SIV-specific CD8+ T cells following
acute SIV infection
We next assessed how SIV-specific CD8+ T cells capable of responding to
stimulation with SIV peptides changed over time, and whether these cells expressed
granzyme B and T-bet. SIV-specific CD8+ T cell functional responses to Tat-TL8 or
Gag-CM9 peptides peaked between 13 and 20dpi in SLT and blood of most animals as
shown in Figure 2-9, similar to the kinetics of Mamu A*01 tetramer binding (Figure
2-5a), then subsequently declined in most animals as infection progressed. One animal
maintained elevated frequencies of CM9- specific functional CD8+ T cell responses up
until necropsy at 90dpi.
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Granzyme B was highly expressed in functional SIV-specific CD8+ T cells
peaking between 13 and 20dpi in LN, spleen and blood, as shown in Figure 2-10a and
Figure 2-10b, similar to granzyme B expression kinetics within Perf+GrzB+ tetramer+
SIV-specific CD8+ T cells (Figure 2-5c and 2-7). Detection of perforin expression was
not performed in CD8+ T cells following SIV peptide stimulation due to lack of
appropriate reagents to detect newly upregulated perforin following stimulation.
Granzyme B expression in responding SIV-specific CD8+ T cells was 2-fold higher in
blood compared to matched sLN during acute infection (Figure 2-10c). Collectively,
these data indicate that responding subsets of SIV-specific CD8+ T cells display rapid
loss of cytolytic protein expression similar to the total SIV-specific CD8+ T cell
population as infection progresses.

53

Supplemental Figure 7
Functional responder SIV-specific CD8+ T cells

0.5

Days post infection

B)

Blood
TL8+
P<0.01

90

41

0.0
pr
e

90

41

20

13

5

10

0.0

1.0

20

0.5

1.5

13

1.0

5

1.5

10
6
2
2.0

10

2.0

% Gag-CM9 Responder

mLN
sLN
Blood
Spleen

pr
e

% Tat-TL8 Responder

A)

Days post infection

sLN
P<0.01

mLN

C)

Spleen
ns

13dpi

ns

CM9+

90dpi

60
40
20
0

%T-bet+ (of GrzB+)

%T-bet+ (of GrzB+)

Figure100
2-9 Functional SIV-specific CD8+ T cell responses throughout
infection
*
100
80
ns

80
60
40
20
0

Frequencies of Tat-TL8 and Gag-CM9 functional CD8+ T cell responses in total CD8+ T
cells following in vitro stimulation from blood, sLN, mLN and spleen
at the indicated
TL8+
ns
P<0.001
P<0.05
P<0.05
CM9+
100
**
time points
*
100
80

d

N
sL

oo
Bl

N
sL

d
oo

80

60

40

pr
e
10
20

80

80
60
40
20
0

Bl

Days post infection

60

40

80
pr
e
10
20

60

40

pr
e
10
20

80

60

40

pr
e
10
20

60
40
20
0

54

Figure 2-10 Functional SIV-specific CD8+ T cell responses lose cytolytic profiles
throughout acute infection
A) Flow cytometry plots of granzyme B and T-bet expression in TL8 and CM9 functional
(CD107a+ and/or IFNγ+ and/or TNF+) SIV-specific CD8+ T cells (TL8 responder in red,
and CM9 responder in blue) overlaid on total CD8+ T cells (black) in blood, sLN, mLN
and spleen at the indicated time points from representative animals. B and D) Kinetics of
granzyme B (B) and T-bet (D) expression in functional TL8 and CM9-specific CD8+ T
cell responses in mLN, sLN, blood and spleen at the indicated time points. Linear
regression ANOVA for samples collected between 13dpi and 90dpi. C and E)
Frequencies of granzyme B (C) and T-bet (E) expression in functional TL8 and CM9specific CD8+ T cell responses in matched sLN and blood samples at 13 or 90dpi. Paired,
one-tailed Student’s t-test; 13dpi (TL8; n=9 pairs and CM9; n=12 pairs) and 90dpi (TL8
and CM9; n=3 pairs). Lines connecting data points represent longitudinally collected data
55

Figure 2-10 continued: from sLN and blood of individual animals. * p<0.05 , ** p<0.01.
No significant differences “ns”.
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Tissue-specific T-bet dysregulation is associated with declining cytolytic SIV-specific
CD8+ T cell functional responses during acute infection
We next evaluated T-bet expression in functional SIV-specific CD8+ T cell
responses in blood, sLN, mLN, and spleen as shown in Figure 2-10d. We observed
similar T-bet expression kinetics among the functional subset of SIV-specific CD8+ T
cells as compared to the total tetramer+ responses in LN, where declining expression
followed peak acute phase at 13dpi (Figure 2-10d and Figure 2-8b). However, unlike
total tetramer+ SIV-specific CD8+ T cells from blood, the functional subset of SIVspecific CD8+ T cells from blood expressed higher levels of T-bet at peak response,
which declined somewhat as infection progressed during the contraction of functional
responses to chronic SIV infection (Figure 2-10d and Figure 2-10b). Unlike total
tetramer+ SIV-specific CD8+ T cells, T-bet expression was significantly higher in blood
as compared to sLN during acute infection, and in CM9-specific responses during
chronic infection (Figure 2-10e). T-bet expression was also higher in TL8-specific
responses from blood during chronic infection in 2 out of 3 animals. The loss of T-bet in
functional cells over time also extended to granzyme B expressing subsets within the
SIV-specific CD8+ T cells in nearly all animals in all tissues (Figure 2-11a). Similar to
total responses, functional responses expressing granzyme B had a higher frequency of Tbet in responses from blood as compared to sLN throughout infection (Figure 2-11b).
These data show that the association between T-bet and cytolytic granzyme B expression
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in the functional subsets SIV-specific CD8+ T cells is heightened in circulating responses
compared to LN.
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Figure 2-11 T-bet expression in cytolytic SIV-specific functional responsive CD8+ T
cells
A) Frequencies of T-bet expression in cytolytic (GrzB+) functional SIV-specific CD8+ T
cell responses from blood, sLN, mLN and spleen at the indicated time points. Linear
regression ANOVA for samples collected between 13dpi and 90dpi. B) Frequencies of Tbet expression in cytolytic SIV-specific CD8+ T cell responses in matched sLN and
blood at 13dpi and 90dpi. Paired, one-tailed Student’s t-test; 13dpi (n=10 to 12 pairs) and
90dpi (n=3pairs).
Lines connecting data points represent longitudinally collected data from sLN and blood
of individual animals. * p<0.05 , ** p<0.01. No significant differences “ns”.
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Transcriptional requirement for maintenance of granzyme B expression following
degranulation is dysregulated during chronic infection
To evaluate the role of T-bet in the maintenance of granzyme B within functional
SIV-specific CD8+ T cells, we assessed whether granzyme B expression in degranulating
SIV-specific CD8+ T cells was preferentially maintained in T-bet expressing cells. As
shown in Figure 2-12a and b, degranulating SIV-specific CD8+ T cells that express T-bet
were significantly higher in granzyme B expression levels during the acute phase in both
blood and sLN compared to T-bet negative cells. However, after establishment of
chronic infection, this relationship was lost. Regardless of T-bet expression,
degranulating SIV-specific CD8+ T cells fail to express high levels of granzyme B in
both blood and sLN. Similar observations were made for both TL8 and CM9-specific
CD8 responses indicating that this loss of proper regulation of cytolytic factor expression
occurs independent of epitope specificity and viral escape patterns.
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Figure 2-12 T-bet expression sustains cytolytic potential following degranulation
during acute infection
A) Flow cytometry plots of T-bet and CD107a staining in CD8+ T cells following in
vitro SIV peptide (Tat-TL8 or Gag-CM9) stimulation at the indicated time points from
blood and sLN. Gated frequencies represent the percentage of T-bet+ or T-bet-events
among CD107a bright events. Histograms of granzyme B expression in CD107a bright,
T-bet+ (blue) and T-bet- (red) CD8+ T cell responses corresponding to the above flow
cytometry plot. Gated regions indicate the frequency of granzyme B+ events (MFI of
granzyme B in parenthesis) from the indicated parent gate above. B) MFI of granzyme B
in matched CD107a bright, T-bet+ and T-bet-, events from blood and sLN at the
indicated time points. Paired, one-tailed Student’s t-test; 13dpi (n=9 to 12 pairs) and
90dpi (n=3pairs). * p<0.05 , ** p<0.01, and ***p<0.0001. No significant differences
“ns”.
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Chapter 2.4 Discussion
It has long been appreciated that CD8+ T cells play a critical role in controlling
viremia during acute and chronic SIV infection. However, the mechanisms underlying
the ineffectiveness of CD8+ T cells to mediate control as disease progresses have
remained unclear. Recent studies of acute HIV infection from our group have highlighted
cytolytic HIV/SIV-specific CD8+ T cell responses developing in peripheral blood very
early in acute infection, but subsequently losing cytolytic factor expression following
resolution of acute viremia (130, 159). To date, most studies have primarily characterized
CD8+ T cell responses from peripheral blood; however, viral replication occurs primarily
in tissues such as SLT and gut mucosa. As such, it is unknown if HIV/SIV-specific
cytotoxic CD8+ T cell responses are present in critical anatomical locations during acute
infection, and if so, whether these responses decline or are maintained after acute
infection.
In the current study, we investigated the evolution of SIV-specific CD8+ T cells
from blood, LN, spleen and gut mucosa of SIV infected RM during acute infection and
through the transition to the chronic phase. We found that the cytolytic proteins perforin
and granzyme B were initially expressed in SIV-specific CD8+ T cells in tissues where
viral replication and reservoir are established during the earliest phases of infection.
However, this early expression of cytolytic proteins collapsed following peak CD8+ T
cell response in all anatomical sites as infection progressed, due in part to an inability to
maintain high levels of the transcription factor T-bet, a known regulatory factor of CD8+
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T cell cytolytic functions. Overall, the short-lived cytolytic profile of SIV-specific
responses within tissues suggests that cytotoxic T lymphocyte dysregulation is initiated in
the earliest responses with suboptimal induction of cytolytic factor expression in SIVspecific CD8+ T cells during acute infection leading to insufficient maintenance of CTL
responses.
In addition to declining expression of cytolytic proteins in SIV-specific CD8+ T
cells following peak viremia, we found tissue-specific disparities in expression of
perforin, granzyme B, and the transcription factor T-bet that provide some resolution to
the previously described observation of poor effector functions in CD8+ T cells from LN
tissue during chronic HIV infection (157). Our detection of both lower T-bet and
cytolytic protein expression in the earliest SIV-specific CD8+ T cells in sLN as compared
to blood suggest tissue-specific downregulation of cytolytic factor expression and/or
impaired replenishment following degranulation in these responses. Importantly, these
tissue-specific expression profiles are detected in both TL8 and CM9-specific CD8+ T
cell responses, possibly supportive of extrinsic, tissue-induced regulation of T-bet as
opposed to intrinsic regulation mediated by TCR signaling or availability of cognate
antigen. These results suggest that SLTs provide an environment where CD8+ T cell
ability to directly eliminate infected cells is hampered, favoring establishment and
persistence of HIV reservoirs. As such, it is likely that CD8+ T cell surveillance within
lymphoid tissues is mediated in part by non-cytolytic CD8+ T cell functions (97, 98).
Declining levels of T-bet in peripheral blood virus-specific CD8+ T cells have
been shown to parallel the loss of cytolytic factor expression and disease progression in
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chronic HIV, HCV and HBV infections (129, 130). The early induction of perforin and
granzyme B co-expression in SIV-specific CD8+ T cells in the absence of high levels of
T-bet and even in T-bet deficient cells, suggest that alternate mechanisms are likely
involved in regulating the initial cytolytic program. This alternatively regulated
induction may be driven by other transcription factors including Eomes, Blimp1, or
Runx3 as previously described (102, 103). Importantly, the short-lived co-expression of
perforin and granzyme B implies that initial high and persistent levels of T-bet, may be
necessary to maintain cytolytic factor expression. Indeed, while SIV-specific CD8+ T
cell responses expressing T-bet initially maintained granzyme B expression following
degranulation in responses from SLT and blood, later in infection T-bet expression
became de-coupled from granzyme B re-expression in stimulated SIV-specific CD8+ T
cells. These results point to additional regulatory deficiencies within SIV-specific CD8+
T cells that result in an inability to maintain cytolytic activity.
It is well accepted that T cell exhaustion occurs in chronic HIV/SIV infection
(133, 138, 164, 165). However, it is unclear how early manifestations of exhaustion first
appear. Experiments in mouse models suggest that even during the acute phase of
clone13 chronic LCMV infection, there are early indicators of exhaustion (127). Here, by
90 dpi, we can already observe an inability of SIV-specific CD8+ T cells to upregulate
granzyme B after stimulation. A similar observation was previously made in chronic
HIV infection by Migueles and colleagues (83). Importantly, we now show that this
develops extremely rapidly, in both blood and lymphoid tissue, and that at least one cause
of this dysfunction is the de-coupling of granzyme B expression from T-bet regulation.
64

While we did not measure markers of exhaustion, such as PD-1, due to their association
with T cell activation during acute infection (30, 127, 166) it is clear that this de-coupling
is not simply due to chronic antigen-specific stimulation, as the same inabilities are
manifest in the Tat-TL8 response, which escapes by 20dpi, and the Gag-CM9 response
which does not escape. Importantly, having now found that this functional disparity also
occurs in the RM SIV infection model, we can begin to explore interventional means to
prevent or reverse this dysfunction and thereby determine whether maintaining properly
regulated cytolytic effector functions in SIV-specific CD8+ T cells can modulate
progression outcome.
Here, we have described for the first time the very early, uniform, and precipitous
loss of granule-mediated cytolytic properties of SIV-specific CD8+ T cells that occurs
not only in peripheral blood, but also at key viral replication and reservoir sites within
lymphoid tissue and gut mucosa. The inability for SLT and gut mucosa SIV-specific
CD8+ T cells to effectively maintain cytolytic properties may foster seeding of viral
reservoir and replication in lymphoid follicles under limited immune pressures. These
results have broad implication in the setting of therapeutic HIV reservoir reactivation
strategies, as even re-invigorated HIV/SIV-specific CD8+ T cell responses in lymphoid
tissue may inherently not be capable of eliminating reactivated latently infected CD4+ T
cells. More generally, these findings may address important features of CD8+ T cell
differentiation that limit full acquisition and maintenance of effector capacity within
critical sites for HIV-specific immune surveillance.
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Chapter 3: Distal accumulation of SIV-specific effector
memory CD8+ T cells from lymphoid tissues during acute SIV
infection in Rhesus Macaques
Chapter 3.1 Abstract
Effector CD8+ T cells efficiently clear virus infected cells via cytolytic killing
functions. Poor cytolytic effector CD8+ T cell functions are associated with persistence
of HIV/SIV infection during chronic progressive infection (83, 85, 86, 131, 132).
However, the development and expansion of HIV/SIV-specific effector CD8+ T cells in
tissues harboring virus during the acute phase of infection has not been defined. Using
the RM SIV infection model, we monitored the expansion, activation and development of
SIV-specific CD8+ T cell memory responses throughout acute infection. While we
observed the development and expansion of SIV-specific memory CD8+ T cell responses
at sites of infection (lymph nodes and gut mucosa), we detected low levels of active
retention of SIV-specific CD8+ T cells in SLT where preferential concentration of
effector memory responses was detected in the circulation. Importantly, we observed
persistent but low levels of effector memory responses with cytolytic potential in lymph
nodes and gut mucosa during acute phase of infection, unlike those detected in blood and
spleen. Importantly, the kinetics of SIV-specific memory subset distribution and
cytotoxic potential were independent of epitope specificity and viral escape patterns.
These data highlight low retention or recruitment of cytotoxic effector memory CD8+ T
cells to sites harboring virus suggesting a mechanisms by which virus avoid effector
mediated clearance and establishes persistence.
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Chapter 3.2 Introduction
Following primary HIV/SIV infection, high levels of immune activation including
CD8+ T cell activation develop and persist into the chronic phase of infection (6, 167,
168). Recent work has described high levels of CD8+ T cell activation concurrent with
immense expansion of memory CD8+ T cells in peripheral blood during the acute phase
of HIV infection (130). However, the evolution of CD8+ T cell memory differentiation
and localization to critical anatomical locations where viral reservoir and replication
occur is limited. Specifically, the development of SIV-specific effector and effector
memory CD8+ T cells in close proximity to cells harboring virus is of the most interest.
However, the presence of these CD8+ T cells thought necessary to mediate clearance of
infected cells has not been determined.
Importantly, HIV/SIV infected subjects demonstrating optimal control of virus,
termed elite controllers, downregulate pro-inflammatory signals and maintain a unique
activated CD8+ T cell phenotype following resolution of acute phase viremia in the
absence of antiretroviral therapy (169, 170). At the same time, elite controllers develop
more classical virus-specific CD8+ T cell memory responses in peripheral blood that
remain functionally responsive to viral antigen stimulation and thus correlate with control
of viremia (85, 86, 131, 132, 140, 169). These findings highlight the importance of proper
regulation of acute phase CD8+ T cell activation that fosters proper memory
differentiation and ultimately control viremia.
The development of a robust effector memory CD8+ T cell response is paramount
for clearing infected cells and establishing long-lived memory. Sufficient virus-specific
67

effector/effector memory CD8+ T cells are expanded and migrate to infected tissues to
mediate clearance of infected cells following activation in SLT (171, 172). Upon
clearance or control of infection, reduced immune activation drives attrition of effector
CD8+ T cells and simultaneous expansion of the central memory CD8+ T cell repertoire.
This process is highly regulated and imperative to maintain the integrity of the immune
system, including proper establishment of memory responses.
The ability of virus-specific CD8+ T cells to reach anatomical locations where
infected cells reside is imperative for maximum desirable effector potential. Similarly,
surveillance by central memory cells via re-circulation through SLT is essential for
functional long-lived immunity. Primary immunodeficiencies in factors mediating
lymphocyte trafficking manifest in the inabilities to clear ubiquitous viral infections such
herpes and papilloma viruses that are otherwise managed immunological memory in
healthy individuals (173, 174). However, whether memory CD8+ T cells are retained or
recruited to infected tissues during HIV/SIV infection is unknown. Classical efferent
trafficking of effector and memory CD8+ T cells out of SLT poses concerns around
CD8+ T cell mediated clearance of HIV/SIV infected follicular CD4+ T cells.
The current model of efficient HIV/SIV viral reservoir eradication is centered on
CTL-mediated clearance. This subset of CD8+ T cells express cytotoxic proteins and are
almost always phenotypically effector/effector memory differentiated (171). However,
the presence of SIV-specific CTL outside of the peripheral blood compartment during
acute phase of HIV/SIV infection has not been well defined. As such, mapping the
evolution and tissue-distribution of effector memory CD8+ T cell responses throughout
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infection will help determine whether CTL can reasonably be predicted to mediate
optimal clearance of virus infected cells.
In this study, we sought to define the evolution of effector memory SIV-specific
CD8+ T cell responses during acute SIV infection through longitudinal monitoring of
SIV infected RM. To address this, RM were infected with a high does of SIVmac251 iv
and monitored from pre-infection up until chronic phase of infection. We characterized
activation, cycling and memory differentiation of two dominant SIV-specific CD8+ T
cell responses to Tat-TL8 and Gag-CM9 epitopes in peripheral blood and anatomical
compartments closely associated with viral reservoir and replication (mLN, sLN, spleen,
and gut mucosa). We found differentially high levels of cycling within the SIV-specific
subset of CD8+ T cells as compared to total CD8+ T cells in all evaluated tissues during
acute phase of infection. We found the highest levels of effector memory SIV-specific
CD8+ T cells in the circulation and spleen, and the lowest levels in LN tissues during
acute phase of infection in part due to limited retention of SIV-specific CD8+ T cells.
During the transition to chronic infection, we identified a memory population resembling
tissue resident memory CD8+ T cells in SLT that was not detectable during acute
infection. Most importantly, the effector CTL with cytotoxic potential are limited in
tissues harboring virus and active replication that may foster viral persistence.
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Chapter 3.3 Results
Transient activation and cycling of SIV-specific CD8+ T cell in critical anatomical
locations despite persistent infection
To assess the level of activation and expansion and retention of SIV-specific
CD8+ T cells during acute infection, we monitored the expression of CD69 and Ki67
throughout acute phase of the infection. We detected CD69 expression in TL8 and CM9specific CD8+ T cells in blood, LNs, and spleen during acute infection (Figure 3-1a). We
observed the lowest levels of CD69 expression in TL8 and CM9-specific CD8+ T cells in
SLT during the peak response, at 13dpi (Figure 3-1b). Interestingly, we detected an
increasing proportion of SIV-specific CD8+ T cells expressing CD69 during the
transition to chronic phase of infection where the highest levels were observed between
41 and 90dpi (Figure 3-1b). Unlike SLT, we detected persistent, low levels of CD69
expressed on SIV-specific CD8+ T cells in the blood throughout infection, with the
exception of a few animals that transiently expressed higher levels of CD69 during the
peak response.
We detected Ki67 expression in TL8 and CM9-specific CD8+ T cells during
acute infection in blood, SLT and gut mucosa (Figure 3-1a). We observed the highest
levels of Ki67 in TL8 and CM9-specific CD8+ T cells during the peak CD8+ T cell
response, at 13dpi, followed by a decline in frequency of expression, and therefore
cycling in blood, SLT and gut mucosa during the transition to chronic infection and as
CD8+ T cell responses contracted (Figure 2-5, and Figure 3-1a, c and d). Notably, CM970

specific CD8+ T cells in gut mucosa appeared to maintain higher levels of Ki67 into late
acute phase of infection, at 41dpi, unlike those with TL8-specificity (Figure 3-1d). TL8specific responses in gut mucosa rapidly lost Ki67 in concert with viral escape patterns
(Figure 2-3b and Figure 3-1d). Importantly, the kinetics of Ki67 were independent of
epitope specificity, but appeared to be highly dependent on anatomical location.
Lastly, we compared the kinetics of CD69 and Ki67 expression in TL8 and CM9specific CD8+ T cells with those among total CD8+ T cells. We found the overall
kinetics of CD69 expression to be similar between SIV-specific and total CD8+ T cells,
where frequencies of expression in total CD8+ T cells fell between those detected in
CM9 and TL8 responses (Figure 3-1e). On the contrary, we observed unique kinetics of
Ki67 expressed in TL8 and CM9-specificic responses that were not detected in total
CD8+ T cells, which might otherwise be expected during bystander activation (Figure
3-1e). Collectively, these data show that SIV-specific CD8+ T cells have a short-lived
activated cycling phase during acute SIV infection.
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Figure 3-1 SIV-specific CD8+ T cells are activated during acute infection.
A) Flow cytometry plots of CD69 and Ki67 expression in TL8 (Red) and CM9 (Blue)
tetramer+ CD8+ T cells from blood, sLN, mLN, and spleen at the indicated time points at
the indicated time points. Tetramer+ events are overlaid on total CD8+ T cells (black) in
that sample. Data are from representative animals. B and C) Kinetics of CD69 (B) and
Ki67 expression (C) in TL8 and CM9 tetramer+ CD8+ T cells in blood, sLN, mLN, and
spleen throughout infection. Lines connecting data points represent longitudinal
monitoring from a single animal. D) Kinetics of Ki67 expression in TL8 and CM9
tetramer+ CD8+ T cells in rectal biopsies throughout infection. E) Average frequencies
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Figure 3-1 continued: (± SEM) of CD69 and Ki67 expression in SIV-specific and total
CD8+ T cells in the indicated tissues throughout acute phase of infection.
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Tissue retention of functional SIV-specific CD8+ T cells develops during chronic
phase of infection
We next looked to evaluate the relationship between cycling, activation and
retention in SIV-specific CD8+ T cells during the acute phase of infection. During peak
response, we observed similar expression profiles of Ki67 and CD69 on SIV-specific
CD8+ T cells in LN and spleen as shown in Figure 3-2a. Importantly, during the peak
expansion and activation of SIV-specific CD8+ T cells (peak Ki67+), we observed the
lowest frequency of CD69 among cycling CD8+ T cells that however progressively
became inverse as infection progressed to the chronic phase (Figure 3-2b).
These data describe limited retention capacity of the most recently activated and
cycling SIV-specific CD8+ T cells in the SLT, yet progressive retention of cells that
resemble Trms as infection progresses to the chronic phase.
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Figure 3-2 Non-cycling SIV-specific CD8+ T cells are retained in SLT following
acute phase of infection.
A) Mean frequencies (+/- SEM) of CD69 and Ki67 expression on TL8 and CM9
tetramer+ CD8+ T cells throughout infection from blood, sLN, mLN, and spleen. B)
Frequencies of Ki67 expression in CD69+ TL8 and CM9 tetramer+ CD8+ T cells in
blood, sLN, mLN and spleen throughout infection. Lines connecting data points represent
longitudinally monitored animals.
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Tissue-specific compartmentalization of CD8+ T cells is associated with poor
retention of effector memory SIV-specific CD8+ T cells in lymph nodes
We next sought to evaluate the development and tissue distribution of SIVspecific memory CD8+ T cells during acute infection in blood, sLN, mLN, spleen and
gut mucosa. We detected effector, transitional and central memory differentiated SIVspecific CD8+ T cells in all evaluated tissues during acute infection as shown in Figure
3-3a and b. We observed an expansion and predominant representation of effector
memory TL8 and CM9-specific CD8+ T cells as compared to central and transitional
memory differentiated cells in blood and spleen during the peak of acute infection in the
blood and by 41dpi in spleen (Figure 3-3c Figure 3-3e). Subsequent to peak response, we
observed a decline in the proportion of effector memory SIV-specific CD8+ T cells in
blood reaching similar frequencies of central and transitional memory CD8+ T cells
during the transition to chronic phase of infection (Figure 3-3c and 3-3e). Similar kinetics
of effector memory CD8+ T cells were detected among total memory CD8+ T cells in
blood and spleen (Figure 3-3c).
At the same time however, we observed low frequencies of effector memory
differentiated SIV-specific CD8+ T cells in sLN and mLN throughout acute infection that
persisted into chronic infection (Figure 3-3c). Similar kinetics of effector, transitional and
central memory differentiated total memory CD8+ T cells were detected in sLN and
mLN throughout acute infection (Figure 3-3c and Figure 3-3e). Among responses in the
gut mucosa, we detected moderate, but persistent levels of effector memory differentiated
SIV-specific CD8+ T cells throughout infection (Figure 3-3d).
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We next compared the representation of each memory subset of SIV-specific
CD8+ T cells between blood and sLN, and identified tissue-specific differences in
memory representation during acute phase of SIV infection. We observed a lower
proportion of central memory differentiated SIV-specific CD8+ T cells in blood as
compared to those in sLN during acute infection (Figure 3-3f). Conversely, we detected a
significantly greater proportion of effector memory differentiated TL8 and CM9-specific
CD8+ T cells in blood as compared to matched sLN. Significantly greater frequencies of
transitional memory TL8-specific CD8+ T cells were detected in sLN as compared to
matched blood during the acute phase of infection, however no significant differences in
the frequencies of transitional memory CM9-specific CD8+ T cells were detected
between blood and sLN during acute phase of infection.
These data indicate limited accumulation of effector memory SIV-specific CD8+
T cells in LN tissues and gut mucosa harboring virus where effector CD8+ T cells are
thought necessary to mediate clearance of infected cells or control of virus replication.
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Figure 3-3 Tissue-specific distribution of SIV-specific memory CD8+ T cells
throughout infection.
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Figure 3-3 continued: A) Flow cytometry plots of CD28 and CD95 expression on TL8
(Red) and CM9 (Blue) tetramer+ CD8+ T cells in blood, sLN, mLN and spleen at the
indicated time points pre- and post-infection. Tetramer+ events are overlaid on total
CD8+ T cells (black) within that sample. Data shown are from representative animals.
Phenotypic identification of memory subsets by CD28, CD95 and CCR7 are shown. B)
Flow cytometry plots of CD28 and CD95 expression on TL8 and CM9 tetramer+ CD8+
T cells from rectal biopsies at the indicated time points pre- and post-infection. C and D)
Frequencies of Central memory (cMem), Effector memory (Eff Mem), and Transitional
memory (Tr Mem) differentiated SIV-specific and total CD8+ T cells in (C) blood, sLN,
mLN and spleen, and (D) rectal biopsies at the indicated time points throughout infection.
Lines represent mean values of the indicated subsets (+/- SEM). E) Frequencies of the
indicated memory subsets among TL8 and CM9 tetramer+ CD8+ T cells during acute
(13dpi) or chronic (90dpi) phases of infection in blood and sLN. Students t-test, corrected
for multiple comparisons, 13dpi (n=? pairs) and 90dpi (n=? pairs) F) Frequencies of Eff
Mem, cMem, and Tr Mem differentiated tetramer+ CD8+ T cells in blood and matched
sLN at 13dpi (n=? pairs) and 90dpi (n=3 Pairs). One tailed, paired students t-test. ).
*p<0.05, **p<0.01, ***p<0.0001.
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Accumulation of functional responsive effector memory CD8+ T cells distal to
tissues harboring virus
We next monitored the frequencies of central, transitional and effector memory
differentiated CD8+ T cells among cytokine producing (IFNγ and TNF) and
degranulating (CD107a staining) SIV–specific CD8+ T cell responses following in vitro
SIV peptide stimulation.
We detected high frequencies of effector memory differentiated TL8 and CM9responder CD8+ T cells in blood and spleen during acute infection that subsequently
declined in the blood yet persisted in spleen as infection progressed to the chronic phase
(Figure 3-4a and b). At the same time, we observed persistent, low frequencies of effector
memory differentiated TL8 and CM9-responder CD8+ T cells in sLN and mLN during
acute and chronic phases of infection (Figure 3-4b).
Importantly, a significantly higher proportion of effector memory as compared to
central and transitional differentiated TL8 and CM9-responder CD8+ T cells were
detected in blood during acute infection that however did not persist into the chronic
phase of infection (Figure 3-4c). Conversely, we observed significantly lower levels of
effector memory as compared to central or transitional memory differentiated TL8 and
CM9- responder CD8+ T cells responses in sLN during acute infection (Figure 3‑4c).
Similar TL8 and CM9-specific CD8+ T cell memory subset distributions in sLN were
observed among total tetramer+ SIV-specific CD8+ T cells during acute infection as
shown in Figure 3-3c and 3-3e. As such, these data describe limited accumulation of
functionally responsive SIV-specific effector memory CD8+ T cells in tissues harboring
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virus where their functions are thought most efficacious to mediate clearance of infected
cells.
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Figure 3-4 Functional effector memory SIV-specific CD8+ T cells are best
represented in the circulation.
A) Flow cytometry plots of CD28 and CD95 expression on TL8 (Red) or CM9 (Blue)
peptide responder SIV-specific CD8+ T cells from blood, sLN, mLN and spleen during
acute and chronic phases of infection from representative animals. Peptide responder
CD8+ T cells are overlaid on total CD8+ T cells within that sample. B) Frequencies of
cMem, Eff Mem, and Tr Mem differentiated TL8 and CM9 peptide responder CD8+ T
cells in blood, sLN, mLN, and spleen throughout infection. Lines represent average
representation of each memory subset. C) Frequencies of memory subsets among TL8
and CM9 peptide responders CD8+ T cells in blood and sLN at 13dpi and 90dpi. Student
t-test, corrected for multiple comparisons. *p<0.05, **p<0.01, ***p<0.0001.
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Aberrant cytolytic factor expression in SIV-specific memory CD8+ T cells during
acute SIV infection
Cytolytic CD8+ T cell functions are typically present in effector and effector
memory CD8+ T cells to mediate clearance of target cells, and generally absent from
central memory CD8+ T cells (46, 171). We monitored the memory distribution of
cytolytic, Perf+GrzB+, SIV-specific CD8+ T cells throughout infection and detected
perforin and granzyme B expression in central, transitional and effector memory
compartments in blood, LN, spleen and gut mucosa during SIV infection (Figure 3-5a
and b). We observed a preferential effector memory profile of Perf+GrzB+ SIV-specific
CD8+ T cells in blood and spleen during acute phase of infection that contracted as
infection progressed (Figure 3-5c) At the same time, we detected persistent low levels of
effector memory Perf+GrzB+ TL8 and CM9-specific CD8+ T cells in sLN, mLN and gut
mucosa during acute infection (Figure 3-5c and Figure 3-5d). Surprisingly, CM9-specific
CD8+ T cells in mLN gained effector memory responses as infection progressed to the
chronic phase. On the other hand, we consistently detected the lowest proportion of
Perf+GrzB+ SIV-specific CD8+ T cells as central memory differentiated cells in all
tissues with the exception of CM9-specific CD8+ T cells in blood and sLN (Figure 3-5c).
We next compared the proportion of memory responses between matched blood
and sLN during acute and chronic phases of infection. We detected a significantly higher
proportion of effector memory Perf+GrzB+ SIV-specific CD8+ T cells in blood as
compared to matched sLN during acute infection, but not during chronic phase of
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infection (Figure 3-5e) Conversely, we observed a significantly higher proportion of
central memory Perf+GrzB+ SIV-specific CD8+ T cells in sLN as compared to blood
during acute infection. However, this was last as infection progressed to the chronic
phase of infection. Overall, few differences in transitional memory Perf+GrzB+ SIVspecific CD8+ T cells were detected except in TL8-specific CD8+ T cells.
Collectively, these data show preferential localization of cytolytic effector
memory SIV-specific CD8+ T cells to the blood and spleen during the acute phase of
infection, but not to LN tissues or gut mucosa where viral reservoir and replication in
CD4+ T cells is present.
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Figure 3-5 Cytolytic SIV-specific CD8+ T cells are limited in lymph nodes during
acute SIV infection.
A) Flow cytometry plots of CD28 and CD95 expression in TL8 (Red) and CM9 (Blue)
tetramer+ CD8+ T cells co-expressing perforin and granzyme B from blood, sLN, mLN,
and spleen at 13dpi and 90dpi. Cytolytic tetramer+ events are overlaid on total CD8+ T
cells (black) from that sample. Representative flow plots are shown. B) Flow cytometry
plots of CD28 and CD95 expression in granzyme B expressing tetramer+ CD8+ T cells
from rectal biopsies at 13dpi and 41dpi, where TL8 and CM9 tetramer+ events are
overlaid on to total CD8+ T cells from that sample. Representative data plots are shown.
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Figure 3-5 continued: C) Frequencies of cMem, Eff Mem, and Tr Mem differentiated
Perf+GrzB+ TL8 and CM9 tetramer+ CD8+ T cells from blood, sLN, mLN and spleen
throughout infection. Lines represent average representations of the indicated memory
subsets D). Frequencies of cMem, Eff Mem, and Tr Mem differentiated GrzB+ TL8 and
CM9 tetramer+ CD8+ T cells from rectal biopsies throughout infection. Lines represent
average representations of the indicated memory subsets E) Frequencies of Eff Mem,
cMem and Tr Mem differentiated Perf+GrzB+ TL8 and CM9 tetramer+ events from
matched blood and sLN at 13dpi and 90dpi. One tailed, student t-test. *p<0.05, **p<0.01,
***p<0.0001
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Chapter 3.4 Discussion
Correlates of CD8+ T cell effector functions and control of viremia during
HIV/SIV infection have been well described. However, the kinetics and tissue
distribution of these efficacious SIV-specific effector memory CD8+ T cells during the
earliest acute phase of HIV/SIV infection have not been defined. Robust expansion of
effector memory HIV-specific CD8+ T cells was recently reported in peripheral blood
during acute HIV infection that however declined following resolution of peak viremia
(130). Importantly, it is unknown whether the cytolytic subset of effector CD8+ T cells
are present in infected tissues where they are thought necessary to mediate clearance of
HIV/SIV viral reservoir.
Here we monitored the activation, potential for tissue retention and memory
differentiation of SIV-specific CD8+ T cells in blood, sLN, mLN, spleen and gut mucosa
throughout acute phase of SIV infection. We found high levels of cycling in SIV-specific
CD8+ T cells in all tissues, yet a poor indication for active retention of these cells in SLT
during the peak CD8+ T cell response. We conversely detected memory CD8+ T cells in
SLT during chronic infection that preferentially expressed CD69 in the absence of recent
cycling indicating active retention. Throughout acute infection, we detected tissuespecific distribution patterns of SIV-specific memory CD8+ T cells, where contrary to
classic distribution of pathogen-specific CD8+ T cells at sites of infection, few effector
memory SIV-specific CD8+ T cells were present in LN and gut mucosa. Conversely,
preferentially localized in blood and spleen irrespective of epitope specificity and
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cytolytic factor expression. Critically, SIV-specific memory CD8+ T cells with cytolytic
potential are generated but are not concentration at anatomical sites where viral reservoir
and replication occur.
Similar to previous findings, elevated levels of cycling in SIV-specific CD8+ T
cells during acute infection were lost following resolution of peak viremia (163, 175,
176). This loss in cycling maybe due to several factors but most pertinent to SIV
infection may be the loss in cognate antigen or the induction of immune exhaustion.
However, the paralleled kinetics of cycling occurred independently of epitope specificity
and viral escape patterns. In Chapter 2 we confirmed the early escape of TL8 and the
persistence of CM9 canonical epitopes as previously reported by others (115, 116)(see
Chapter 2). Collectively, these findings suggest homeostatic mechanisms are initiated to
reduce expansion of activated SIV-specific CD8+ T cells to ultimately achieve systemic
immune homeostasis and prevent tissue pathology despite persistent antigen.
While the expression of CD69 has historically been used as an outward and
visible sign of recent lymphocyte activation in vitro, the true known function for CD69 is
rather involved in tissue retention (177-179). Our findings of low CD69 expression
among SIV-specific CD8+ T cells in SLT during peak response fits with the model for
efferent trafficking of newly activated CD8+ T cells from SLT for migration to site of
infection. An alternate interpretation might be viewed as expansion of SIV-specific CD8+
T cells that predominantly lack CD69, reducing the overall frequency of CD69+ SIVspecific CD8+ T cells while the true absolute counts may be unchanged or even elevated.
Nevertheless, these data suggest an overall reduction in retained SIV-specific CD8+ T
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cells in infected tissues that is likely unfavorable for increasing the probability of
encountering and clearing an infected CD4+ T cell(s). Moreover, limited retention of
SIV-specific CD8+ T cells in SLT during acute infection indicates fewer cells available
for clearance of infected cells.
Although acute phase retention of SIV-specific CD8+ T cells in SLT appears
limited, accumulation of SIV-specific CD69+ CD8+ T cells during the transition to
chronic phase of the infection that predominantly lack indicators of cycling or recent
activation suggests seeding of tissue-resident memory cells at these sites of infection.
Recent studies have identified a population of tissue-resident memory LCMV-specific
CD8+ T cells in LNs and spleen following LCMV infection in mice, identified
phenotypically by expression of CD69 (74). Our observation of CD69+ SIV-specific
CD8+ T cells developing in SLT following acute SIV infection is temporally similar to
the development of LCMV-specific Trm following acute LCMV infection in mice and
thus speaks to the establishment of SIV-specific CD8+ Trms during the chronic phase of
SIV infection. Nevertheless, the retention of an SIV-specific CD8+ T cell population in
close proximity to viral reservoir may exert pressures contributing to the maintenance of
set point viremia.
While the overall retention of SIV-specific CD8+ T cells at sites of infection is
important, the representation of effector memory SIV-specific CD8+ T cells at these sites
is equally critical. Effector memory CD8+ T cells are the most efficient at executing
sustained cytotoxic functions. Our observations of limited representation of effector
memory SIV-specific CD8+ T cells in LN and gut mucosa during acute infection
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corroborate with the current model of efferent trafficking of newly generated memory
cells from SLT following activation and priming. Not surprisingly, these findings are in
line with previously described tissue-specific distribution of memory CD8+ T cells in
humans and “dirty” mice (70, 76, 180). At the same time, these data show that HIV/SIV
infection of LN and gut mucosa CD4+ T cells does not exempt CD8+ T cells from their
pre-programmed trafficking fate following activation, nor does it appear to affect
recruitment of effector memory responses to LN or gut mucosa. Importantly, high levels
of effector memory responses detected in the spleen are almost certainly not due to
retention of recently activated SIV-specific CD8+ T cells during peak infection (i.e. low
CD69 expression). Rather, these high levels imply contribution from recirculating
effector memory responses in the splenic red pulp (75% composition of spleen) as
opposed to those localizing to secondary lymphoid structures in the white pulp (25%
composition of spleen). As such, our findings suggest that neither retention nor obvious
recruitment of effector memory SIV-specific CD8+ T cells takes place in SLT and gut
mucosa during active infection that is counterproductive for CTL to exercise effector
mediated control of local residing viral reservoir. Further, these findings provide support
for a semi-immune privileged site of the SLT, fostering viral reservoir seeding and
persistent replication.
While effector memory CTL CD8+ T cells are not present at high levels in SLT
or gut mucosa during peak acute infection, transient cytolytic factor expression among all
memory subsets may suffice for resolution of peak viremia, and establishment of viral set
point. Cytolytic factor expression in central, transitional and effector memory
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differentiated SIV-specific CD8+ T cells has previously been described following T cell
activation indicative of comprehensive cytotoxic efforts (181). Despite the effort to
achieve rapid and sufficient cytolytic capacity in CD8+ T cells during acute infection, the
transcriptional profiles of central and transitional memory responses are not equipped to
sustain cytolytic factor expression, as seen with the loss in cytolytic factor expression in
SLT and gut mucosa discussed in Chapter 2. For good reason, the expression of cytolytic
factors is tightly regulated. This regulation prevents bystander destruction of lymphoid
tissue architecture, and prolonged imbalance to the chemokine gradient required to
sustain follicular and germinal center organization albeit while infection persists.
In this study we described the accumulation of effector memory SIV-specific
CD8+ T cells in the circulation as opposed to SLT where infection in concentrated. While
the rapid expansion and efflux of effector responses and collapse in cytolytic potential
(Discussed in Chapter 2) of SIV-specific CD8+ T cells from SLT may be counter
productive for clearance of infected CD4+ T cells in SLT follicles, the immune system
does exert pressure on the virus (viral escape discussed in Chapter 2), resolve peak
viremia and maintain some control of the infection as indicated by stable set point
viremia. These findings suggest that alternate mechanisms other than cytolysis are
involved in the partial control of this persistent infection.
These findings have implications in the feasibility of SIV-specific CTL to mediate
clearance of infected cells and viral reservoir in SLT and gut mucosa. Aside from the
predicted consequences of poor CTL potential in SLT, an effort to maintain partial
control of viremia must be in place. Reasonably, the source of persistent immune
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pressure on viral reservoir in SLT may be derived from the tissue resident memory
(CD69+Ki67-) SIV-specific CD8+ T cell population that accumulates in SLT as infection
progresses to the chronic phase.
Overall, preferential localization of effector memory cytotoxic CD8+ T cells at
distal to sites of infection supports the designation of SLT as a semi-immune privileged
site. Specifically and most importantly, the maintenance of this designation, even during
local acute infection, is favorable to survival of HIV/SIV, yet has serious negative
consequences related to persistence of the infection. Although dampened cytotoxic
effector capacity at sites of infection, a memory CD8+ T cell population resembling
tissue resident memory is likely involved in partial control of viremia via non-cytotoxic
mechanisms.
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Chapter 4: Discussion and Future Directions
Chapter 4.1 Summary of findings
Our study aimed to characterize aspects of cytotoxic CD8+ T cell effector
potential to further define attributes of the earliest SIV-specific CD8+ T cell responses
that are in part influential to the chronicity of HIV/SIV infection. First, we identified an
acute phase restricted expansion and activation profile of SIV-specific CD8+ T cells, as
compared to total CD8+ T cells. This transient profile was detected despite persistence of
viremia where we might otherwise anticipate continued activation and expansion of SIVspecific CD8+ T cells. Second, we observed robust cytolytic potential of SIV-specific
CD8+ T cells in blood, LNs, spleen and gut mucosa, all tissues that are critically involved
in HIV/SIV persistence, at peak acute infection that was however short-lived and
collapsed following the peak CD8+ T cell response. Importantly, the kinetics of SIVspecific CD8+ T cells were independent of epitope specificity and viral escape patterns.
We found expression and persistence of cytolytic factors, perforin and granzyme B, to
parallel the expression of the regulatory factor T-bet during acute and chronic phases of
infection. Specifically, we observed low and declining levels of T-bet in SIV-specific
CD8+ T cells. Third, we identified tissue specific disparities between SIV-specific CD8+
T cells in the blood, LNs, spleen and gut mucosa that were also independent of epitope
specificity or persistence of cognate antigen. These disparities include lower expression
of perforin and reduced maintenance of T-bet expression in SIV-specific CD8+ T cells in
lymphoid tissues as compared to peripheral blood. Lastly, during the transition to chronic
93

phase of infection we identified a decoupling of T-bet expression and the ability to
replenish cytolytic factor granzyme B following degranulation suggestive of a
mechanism for reduced CTL potential.
In addition, we aimed to characterize the kinetics and tissue distribution of
effector memory SIV-specific CD8+ T cells that are thought to traffic to infected tissues
and execute optimal effector functions for clearance of infected CD4+ T cells.
Overwhelmingly, we detected low frequencies of effector memory differentiated CD8+ T
cells in tissues harboring high levels of virus. At the same time, we detected limited
retention of recently activated, cytolytic SIV-specific CD8+ T cells in SLT where their
functions are predicted necessary to mediate clearance of infected CD4+ T cells.
Interestingly however, during the transition to chronic phase of infection, we identified
accumulation of SIV-specific CD8+ T cells that phenotypically resemble Trms. We
hypothesize that these Trms may contribute to the maintenance of set point viremia via
non-cytolytic functions. Further, we identified central and transitional memory
differentiated SIV-specific CD8+ T cells with untypical or aberrant cytolytic factor
expression among the earliest detectable responses from all evaluated tissues
demonstrating an exemplary effort by the immune system for granular-mediated
cytotoxic clearance of infected CD4+ T cells.
Indeed, our findings have allowed us to make implications on early dysregulation
of the CD8+ T cell cytotoxic effector function yet an effort to establish local immunesurveillance as infection progresses to the chronic phase. Most importantly, these
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observations in crucial anatomical sites harboring virus elucidate several tissue specific
mechanisms of immune-suppression that foster the chronic nature of HIV/SIV infection.

Chapter 4.2 Implications of findings
Chapter 4.2.1 Implications for tissue specific restraint on CD8+ T cell effector
capacity and persistence of viral reservoir
Our study addresses some of the gaps in understanding CD8+ T cell cytotoxic
profiles in anatomical locations where viral reservoir and replication are known to be
highly concentrated. The functional capacity of CD8+ T cell effector responses within
SLT are thought to be poor during chronic HIV/SIV infection and include limited
accessibility to target infected cells. These inferior and insufficient CTL functions are
hypothesized to be consequential of an immune privileged environment established in the
SLT (120, 122, 157, 160). However, the mechanisms and context in which this semiimmune privileged environment manifest are unknown.
We first addressed a critical question of whether the immune system actually can,
and does generate cytolytic CD8+ T cell effector responses to SIV during the initial phase
of infection and found that these responses were generated. Chiefly, we next addressed
whether these responses are ever present where they are thought to be most functionally
essential to mediate clearance of infected cells, including LN, spleen and gut mucosa
(120). Our detection of qualitatively inferior cytotoxic CD8+ T cell responses in LN as
compared to matched peripheral blood during acute phase of infection highlights the
disparities of immune functions between these two compartments.
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These disparities include significantly lower perforin for pore formation in target
cells, refractory granzyme B replenishment following degranulation and lower
frequencies of T-bet expressing functionally responsive SIV-specific responses. These
distinctions highlight the importance of comprehending disparities in anatomical location
and environments when looking to evaluate circulating responses as surrogate for tissue
residing responses. At the same time, these findings can generate new interpretations of
many previously published studies that may clarify and facilitate a new model for
understanding HIV/SIV persistence and immune evasion. For example, peripheral blood
has historically served as a surrogate for monitoring the systemic immune compartment
during HIV/SIV infection. Using peripheral blood, several groups, including our own,
have reported superior cytotoxic functionalities of HIV/SIV-specific CD8+ T cells in
elite controller subjects as compared to lower levels detected in chronic progressors.
However, data in this thesis suggest that cytotoxic functionalities in tissue harboring virus
are lost early during the acute phase of infection. As such, the focus on granule-mediated
cytolysis as the responsible mechanism for the establishment and maintenance of set
point viremia should be challenged in both elite controller and chronic progressive
subjects. Additionally, the strategy of reactivation of viral reservoir with HDAC
inhibitors (Discussed in Chapter 2) depends heavily on the assumption that CTL can
reach viral reservoir in SLT and gut mucosa, and upon arrival can mount robust cytotoxic
killing functions. The data in this thesis challenges the feasibility of this therapeutic
strategy.
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It is important that we note our study did not include evaluation of absolute
cytolytic killing functions, nor factors associated with dampening of the effector
functions in lymphoid tissues. Rather, these studies evaluated the phenotypically defined
effector memory cells and expression of factors necessary for mediating granulemediated cytolysis and functional responsiveness to stimulation with SIV peptides.
These approaches allowed us to determine whether and to what degree SIV-specific
CD8+ T cells from various critical anatomical compartments have cytotoxic potential,
respond to peptide stimulation and maintain this profile over time. We did not evaluate
signals induced by tissue residing cells, such as fibroblasts or dendritic cells, that may be
associated with dampening of T cell activation, nor did we evaluate inhibitory receptors
that may be associated with receiving such signals (i.e., PD-1, 2B4, Lag-3 among others).
Nevertheless, we have resolved the question of whether acute phase SIV-specific CD8+
T cells in anatomical locations harboring viral reservoir express necessary factors for
granule mediated cytolysis (Perf+GrzB+) and sustain an efficacious effector CD8+ T cell
profile (T-bet). Collectively, these data provide support for defining LN as semi-immune
privileged tissue and highly suggest that virus avoids immune pressures in these tissues to
establish long term reservoir (Figure 4-1).
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Figure 4-1 Proposed tissue-specific expression of cytotoxic genes during acute SIV
infection
A proposed model of tissue-specific expression intensity of the cytolytic factors in SIVspecific CD8+ T cells evaluated in this study.
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Chapter 4.2.2 Implications for retention/sufficiency of effector responses in infected
secondary lymphoid tissues.
Our detection of limited retention and accumulation of effector memory
differentiated SIV-specific CD8+ T cells in LN tissues (Discussed in Chapter 3) has
implications in the sufficiency of local cytolytic responses for clearance of HIV/SIV
infected cells. Current models of CD8+ T cell memory differentiation and expansion
describe efferent trafficking of recently activated and primed T cells from lymphoid
tissue to sites of infection via the circulation (Figure 4-2). This migration out of SLT is in
place for efficient delivery of effector cells to infected tissues and immediate systemic
surveillance by central memory cells. Similarly, during primary SIV infection, the
majority of newly generated effector memory SIV-specific CD8+ T cells in SLT do not
express retention markers and are found concentrate in the circulation. Ideally, retention
of effector CD8+ T cells in SLT during acute HIV/SIV infection will more efficiently or
completely eliminate infected cells and prevent establishment of viral reservoir.
Conversely, limited retention of SIV-specific CD8+ T cells would be counter-productive
for CTL-mediated clearance of infected cells in these tissues as we and others have
reported (Figure 4-2).
Importantly, our study did not define the absolute changes in CD8+ T cells that
demonstrate retention capabilities (CD69) or effector memory phenotypes (CD28CD95+CCR7-). As such, the changes that we observed in the proportion of these cells
may not reflect absolute numbers of these populations in the evaluated tissues.
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Nevertheless, SIV is highly concentrated in CD4+ follicular T cells and thus CD8+ T
cells, whether newly activated and primed, or recently differentiated from long-lived
memory cells should be actively retained in these infected. Along these lines, this study
did not determine the consequences of retaining SIV-specific CD8+ T cells in LN or
spleen to evaluate whether retention or accumulation of these responses at sites of
infection positively influences clearance of infected cells and viral reservoir. Currently,
our lab is designing a RM SIV infection study to address this question using FTY70
small molecule inhibitor of lymphocyte egress from SLT.
Our findings imply that the default fate of activated SIV-specific CD8+ T cells to
egress from SLT is not redirected towards retention or accumulation of effector memory
responses even in the presence of local lymphoid tissue infection. Moreover, the lack of
effector memory accumulation at these infected sites lessens the probability for CTL to
encounter target infected cells and implies yet another route by which the virus avoid
immune clearance.
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Figure 4-2 Proposed model of CD8+ T cell activation and memory distribution as it
relates to highly infected tissues during acute SIV infection in rhesus macaques
A) Proposed model for SIV-specific memory CD8+ T cell distribution in anatomical sites
harboring viral reservoir and replication during acute SIV infection. B) Modeled kinetics
of total and SIV-specific CD8+ T cell responses (TL8 and CM9 dominant epitopes) in
101

Figure 4-2 continued: anatomical compartments harboring virus during acute and
through the transition to chronic phase of infection. Pre-infection CD8+ T cell memory
subset distributions are shown for blood, gut mucosa and LN.
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Chapter 4.2.3 Implication for T-bet dysregulation of cytotoxic functions
Undoubtedly our results suggest dysregulation of cytolytic factor expression and
replenishment in association with T-bet expression in SIV-specific CD8+ T cell
responses during early infection. Our observations in LN and blood describe the
paralleled loss in replenishment of granzyme B following degranulation of SIV-specific
CD8+ T cells in the absence of T-bet expression. Additional observations in peripheral
blood described decoupled T-bet expression with the ability to maintain granzyme B
expression following degranulation during chronic phase of infection. These findings
imply that active mechanisms may be in place to suppress T-bet functions to sustain
cytolytic profiles in SIV-specific CD8+ T cell responses as infection progresses.
Our observations and interpretations around T-bet and cytotoxic factor expression
are limited. We did not evaluate other possible regulators of the effector program such as
Rux3, Blimp1, or Eomes among others. However, it is well established that T-bet
expression is indispensible for maintaining the robust expansion and functionality of
effector CD8+ T cells as shown by many. The decoupling of T-bet from maintenance of
granzyme B is suggestive of induction of the early induction immune exhaustion.
Although, this study did not characterize the induction kinetics of immune exhaustion as
discussed in Chapter 2.4 and again in Chapter 4.2.4. We can speculate that negative
regulation of cytolytic factor expression may overcome positive regulation by T-bet
during the transition to chronic phase of infection. Such mechanisms may include
negative regulation by Bcl-6, PD-1 or TGFβ induced regulation or possible regulation at
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a translational level. Reasonably, multiple mechanisms working together may
collectively present in this decoupling.
These findings contribute to hypotheses around regulation and dampening of
effector functions that contribute to chronicity of HIV/SIV infection. Further,
transcriptional dysregulation of the effector program by T-bet is closely linked to the idea
of an immune privileged site ripe for viral reservoir persistence, yet be a necessary
regulatory process for host survival.
Chapter 4.2.4 Implications in immune homeostasis
A biological necessity is implicit in the short-lived cytolytic factor expression and
limited retention of effector CTL in lymphoid tissues. We propose that mechanisms of
homeostasis are influential in the evolution of SIV-specific CD8+ T cell effector
responses as early as the acute phase of HIV/SIV infection. The synchronous collapse in
cytolytic factor expression and near uniform kinetics of T-bet expression in SIV-specific
CD8+ T cell responses in blood, LN, spleen and gut mucosa during acute phase of SIV
infection are highly suggestive of induction of immune homeostasis or even of the state
of immune exhaustion.
Paralleled kinetics between TL8 and CM9-specific CD8+ T cells that experienced
either loss (TL8) or persistence (CM9) of cognate antigen imply a default induction of
immune regulation. Such mechanisms could include downregulation of type I interferons
and interferon stimulated genes, positive regulation of anti-inflammatory profiles
including expansion of T regulatory cells and anti-inflammatory cytokine including
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TGFβ, IL-10 among others. Anti-inflammatory mechanisms throughout the acute phase
of infection should be investigated in particular the temporal relationship to the collapse
in the cytotoxic profiles during early acute HIV/SIV infection.
Evidence for immune exhaustion has been evaluated during the chronic phase of
HIV/SIV infection (133, 138, 182), however little known about the evolution of immune
exhaustion as early as the acute phase of infection. It may be implicit in these findings
that some aspects of CD8+ T cell exhaustion are initiated during this early phases of
infection (discussed in Chapter 2). However, evidence suggesting a more global
induction of immune homeostasis is discussed above. The classical environment for
CD8+ T cell exhaustion describes addiction or dependence of exhausted CD8+ T cells on
cognate antigen for survival despite lack of responsiveness or effector functions (183,
184). This description of chronic antigen stimulation despite poor effector functionality
does not fit with the full escape of canonical TL8 epitope by 20dpi. Indicators of immune
exhaustion including PD-1, 2B4, Lag3, CD160, TIGIT among others, were not evaluated
in this study, yet deserve attention as immune exhaustion my play a critical role in
chronicity of infection and/or the rate of disease progression.
Although homeostatic regulation of immune activation and effector functions
appears counter productive for control of HIV/SIV infection, especially in cells proximal
to infection, this early establishment may be critical for the survival of the host. Sustained
activation and cytotoxic activity may be more detrimental to the host in comparison to
chronic, persistent infection. However, these states of immune regulation and
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homeostasis were not evaluated in this study, and thus can only be commented on with
speculation.
Chapter 4.2.5 Alternative non-cytolytic mechanisms for control of viremia during
chronic phase of infection
Our current understanding of granule-mediated cytolytic CD8+ T cell killing
requires direct contact with the target infected cell via the immunological synapse, thus
elevating the importance of CTL in close proximity with target infected cells. While we
observed transient cytolytic potential in SIV-specific CD8+ T cells in all evaluated
tissues and limited representation of effector memory responses in LN, virus persisted at
the achieved set point viremia. These findings imply that alternate mechanisms are
responsible for maintaining set point viremia in the absence of SIV-specific CD8+ T cell
cytotoxic killing capacity. In fact, prior studies have proposed and provided evidence for
non-cytolytic mediated suppression of viral replication by CD8+ T cells during chronic
infection (97, 98, 123).
While none of these alternate mechanisms were evaluated in the present study,
their role certainly fits with the kinetics of CTL and the control of set point viremia. Noncytolytic mechanisms that may mediate this process include alpha/beta defensins,
Mip1α/β, TNF and the unclassified factor CAF (8, 80, 92-94). The contribution of these
non-cytolytic factors certainly could account for the maintenance of set point viremia in
the near absence of cytotoxic potential and retained effector memory SIV-specific CD8+
T cells in SLT. Regulation of viral replication in this manner may prevent high levels of
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immune activation and therefore serve the host in a more efficient, less disruptive
fashion. As such, we contribute new hypotheses around non-cytolytic mechanisms of
control of HIV/SIV replication during chronic phase of infection that may be initiated as
early as the acute phase of SIV infection (Discussed in Chapter 2).
Chapter 4.2.6 Impact in efficacy of therapeutic intervention: Reinvigoration
strategies for viral reservoir clearance may be challenging.
Beyond control of primary HIV/SIV infection, the collapse and refractory
expression of cytolytic factors in SIV-specific CD8+ T cells following recall response
has profound implications for therapeutic HIV reservoir reactivation strategies. The
theoretical success for clearance of reactivated latent HIV/SIV reservoirs depends heavily
on CTL mediated killing (83, 85, 86, 115, 118, 131, 132, 169). This strategy implies
dependence on expansion, recruitment and retention of CTL to tissue harboring
reactivated reservoir (LN and gut mucosa) and sustained cytotoxic functionality therein.
The distinct results from our study uncover several concerns for the feasibility of
reinvigorating memory CD8+ T cell responses at sites of infection for efficacious CTLmediated clearance of viral reservoir.
Although validation of virus-specific CD8+ T cell responses in SLT during acute
HIV infection have not been done, Demers et al. recently showed loss of cytotoxic
potential in HIV-specific CD8+ T cells from peripheral blood during acute HIV infection,
validating our results in blood during acute SIV infection in RM (130). Undoubtedly,
CTL kinetics will hold true in critical anatomical locations during HIV infection in
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patients. Moreover, it questionable and appears unlikely that upon reactivation of HIV
latent reservoirs HIV-specific memory CD8+ T cells will rapidly provide fully
programmed and uninhibited CTL effector responses to sites of infection. Briefly, T cell
based vaccine or gene therapy approaches may experience similar hurdles around tissuespecific immune regulation, diverting robust effector CD8+ T cells responses from
residing in target, infected, tissues.
Chapter 4.2.7 Implications for effector CD8+ T cell development
More generally, our findings address important features of CD8+ T cell memory
development. Specifically, restraint on expansion of effector responses and full
acquisition of effector potential may be in place prior to arrival in peripheral blood. This
observation contains features that resemble the phenomenon of lineage priming during
hematopoiesis, where genes involved in lineage specification and commitment can be
transiently expressed, albeit at low levels, prior to de-repression of genes required for that
fate, and subsequent full acquisition of that fate potential (185). We hypothesize that
lymphoid tissue priming of CD8+ effector T cell differentiation includes low expression
of genes that are involved in establishing effector identity which are actively de-repressed
until a contextual or environmental cue is received.
Our lab is currently characterizing lymphocytes from thoracic duct fluid to
confirm the repressed effector profile of CD8+ T cells prior to reaching peripheral blood
in HIV negative and positive subjects. Results from this study thus far provide evidence
for restricted effector profiles of memory CD8+ T cells prior to reaching the peripheral
108

blood circulation. At the same time, identification of this contextual or environmental
cue(s) is under investigation in our lab and includes evaluating the expression of cytolytic
factors and transcription factors that regulate them.
Reasonably, differentiation and full acquisition of effector functions in lymphoid
tissues could be dangerous for survival of APCs presenting cognate antigen. In addition,
the effector capacity maybe deleterious to tissue architecture and the essential balance of
chemokine gradients for new memory formation. (See Chapter 4.2.3)
Chapter 4.2.8 Conclusions and Discussion
Here, we characterized several properties of SIV-specific CD8+ T cells that have
otherwise previously been undefined during acute HIV/SIV infection. Most strikingly is
an exemplary yet short-lived effort by the immune system to initiate granule-mediated
cytolytic potential in nearly all SIV-specific memory CD8+ T cells during the acute
phase of infection. Despite this effort, full expression of cytotoxic factors in SIV-specific
CD8+ T cells in lymphoid tissue and gut mucosa is dampened as compared to those
detected in the circulation. We hypothesize this tissue-specific restraint on cytotoxic
potential along with limited indicators of their retention is in place for lymphoid tissue
preservation. Particularly, this restraint may minimize tissue pathologies associated with
apoptosis and inflammation following execution of granule-mediated cytolysis and the
release of cytotoxic factors in the local environment. Importantly however, neither the
efficacy nor toxicity of retained cytotoxic effector CD8+ T cells at sites of infection were
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evaluated in this study. Nevertheless, we speculate these CTL dampening and selfpreservation mechanisms cultivate the immune-privileged environment of these tissues.
While the immune system demonstrates cytotoxic potential and activity, as
indicated by resolution of peak viremia during acute phase of the infection, this potential
becomes diminished from nearly all SIV-specific CD8+ T cells in all tissues as infection
progresses to the chronic phase. We propose this synchronous collapse in cytolytic
potential is driven by cell intrinsic and extrinsic mechanisms to contain immune
activation, although exact mechanisms responsible for early onset CTL dysregulation
have not been evaluated, yet deserve attention. Certainly, CD8+ T cell exhaustion may
contribute to this phenomenon. Supporting evidence for this hypothesis is seen in the
independence of this phenomenon from epitope specificity, viral escape patterns, and
anatomical location as well as the uncoupling of T-bet from granzyme B expression in
degranulated functional CD8+ T cell responses.
Importantly, how set point viremia is maintained in the absence of robust
cytotoxic CD8+ T cells is not understood. Non-cytolytic CD8+ T cell effector
mechanisms are hypothesized to mediate this partial control of HIV/SIV that may include
CAF (Discussed in Chapter 1), although a mechanism(s) responsible for non-cytolytic
CD8+ T cell mediated control has not been identified (97, 98, 123). Our data indirectly
support this hypothesis but do not address this question directly. Curiously, the
accumulation of Trm SIV-specific CD8+ T cells at sites of infection during chronic phase
of infection is a likely source of non-cytolytic functions for partial control of viremia.
Trms reside at sites of infection and in SLT following acute infection. These resident
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cells provide rapid response to rechallenge or viral replication through various effector
mechanisms including non-cytolytic. As such, we can reasonably speculate that Trms
participate in the control of set point viremia during chronic HIV/SIV infection.
In summary, we show that the immune system provides an illusion of a wellequipped, initial response to HIV/SIV infection through memory differentiation,
expansion and generation of cytotoxic CD8+ T cells (Figure 4-3). However, early
dysregulation in cytotoxic potential driven in part by T-bet dysregulation along with
limited retention of effector memory SIV-specific CD8+ T cells in tissue harboring virus
provide an explanation for the early establishment of viral reservoir in these tissues
(Figure 4-3 and Figure 4-4). While we observe a collapse in CD8+ T cell cytotoxic
potential, despite persistence of infection, a second line of CD8+ T cell defense
responsible for maintaining partial control of infection (set point viremia) may be
mediated by SIV-specific Trm CD8+ T cells that accumulate at these sites following
resolution of acute viremia.
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Figure 4-3 Model of CD8+ T cell cytolytic representation in critical anatomical
compartments during SIV infection in RM
Tissue distribution of cytolytic CD8+ T cell in critical anatomical compartments
including blood, lymph node, spleen, and gut mucosa during SIV infection in RM; acute
phase (A) and chronic phase (B). The relative proportions of non-cytolytic and cytolytic
SIV-specific CD8+ T cells are shown in blood, lymph node, spleen and gut mucosa
during SIV infection; acute phase (A) and chronic phase (B).
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Figure 4-4 Model of SIV-specific CD8+ T cell cytolytic profile in SLT during acute
SIV infection in RM
Comparative frequencies and expression intensities of critical components of cytotoxic
CD8+ T cells and their potential to clear virus infected CD4+ T cells in secondary
lymphoid tissue during peak SIV infection (acute phase) and throughout the transition to
the chronic phase of infection. Expression intensity of the indicated components is
represented by the intensity of shading, where darker shades represent higher expression
and lighter shades represent lower expression.
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Chapter 4.3 Future Directions
Chapter 4.3.1 Identifying tissue-specific cytotoxic and suppressive functional
capacities of CD8+ T cells during acute SIV infection
The cytolytic factor perforin is differentially expressed in SIV-specific CD8+ T
cells between SLT and blood, and granzyme B replenishment following degranulation
during in vitro stimulation is most refractory in responses from LN. Defining true
cytotoxic and antiviral functions of SIV-specific CD8+ T cell responses from blood and
tissues against virus infected CD4+ T cells will more directly define tissue-specific
disparities in cytotoxic potential and the ability to execute this potential. Critically,
determining whether SIV-specific CD8+ T cells in tissues harboring viral reservoir in fact
do carry out killing, or can mediate suppressive antiviral functions will solidify our
hypothesis around tissue induced dampening of CTL functions. We propose functional
target cell killing and suppression assays that can address these gaps in understanding
CTL potential in various anatomical compartments. We are currently in the process of
obtaining results from an in vitro viral suppression assay using sLN and peripheral blood
samples collected in this study.
Chapter 4.3.2 Expression of genes involved in cytolytic functions
The short-lived cytolytic factors expression in the absence of T-bet suggests
alternate transcriptional regulatory mechanisms involved in driving the initial SIVspecific CTL profile (Discussed in Chapter 2). In addition, differential expression of
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perforin, granzyme B and T-bet in SIV-specific CD8+ T cells between blood and SLT
suggest yet another undefined mechanism of CTL regulation. We propose gene transcript
analysis for each of these factors, perforin, granzyme B and T-bet in SIV-specific CD8+
T cells from each of the studied tissue compartments (blood, LN, spleen, gut mucosa).
The evaluation of perforin, granzyme B, and T-bet may inform possible transcriptional
regulation of these factor is addition to our protein analysis by flow cytometry. We
propose to evaluate transcripts of possible alternate transcription factors involved in
regulation of cytolytic factor expression as well as those that might be involved in active
repression of the effector network including Eomes, Blimp-1, Runx3, Bcl-6, Tcf1, Foxo1
and many others. Nevertheless, gene transcript studies may help define mechanisms of
immune dysregulation or mechanisms of immune suppression that are components of, but
not limited to, the chronic nature of HIV/SIV infection.
Chapter 4.3.3 Induction of immune exhaustion
Some of the findings in this study may indicate CD8+ T cell exhaustion as a
mechanism for lost cytotoxic potential during acute SIV infection (47, 127). However,
the induction of immune exhaustion in relationship to the loss in cytolytic profiles
throughout infection was not included in this study, yet certainly affords attention. We
propose evaluating the evolution of inhibitory receptor expression patterns in relation to
polyfunctionality and cytotoxic potential of SIV-specific CD8+ T cell responses
throughout acute phase of infection. More in depth analysis of exhaustion profiles in SIVspecific CD8+ T cell from critical anatomical compartments throughout acute SIV
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infection should be done including transcriptional and epigenetic profiling of genes
involved in the establishment of exhaustion (127, 128, 137, 186). These studies may too
provide evidence for the environmental or anatomical context in which induction of
exhaustion begins.
Chapter 4.3.4 Tissue residing memory SIV-specific CD8+ T cells and non cytolytic
mechanisms of control
Based on the identification of a population of SIV-specific CD8+ T cells that
closely resembles Trm, we propose to further evaluate the phenotype of these SLT
residing responses. In addition to rigorously evaluating their phenotype, we propose to
evaluate the cytotoxic and non-cytotoxic functional capacities of these cells extracted
from tissues of chronically infected RM. A similar functional assay described in Chapter
4.3.1 would provide details on these questions. To further evaluate the proximity of these
SIV-specific CD8+ T cells to viral reservoir in lymphoid follicles, we propose to perform
tissue sectioning and immunofluorescence microscopy on LN and spleen sections from
these animals. Identification of the precise anatomical location of these Trm like SIVspecific CD8+ T cells within SLT will provide further understanding as to their role in
SLT tissue, and most importantly their potential role in containing virus to follicular
regions of SLT during chronic infection.
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Chapter 5: Methods
Chapter 5.1 Ethical Statement for use of non-human primates
Procedures carried out in this study were performed following an Institutional
Animal Care and Use Committee (IACUC) of Emory University approved protocol,
number #YER-2002541-121716GA in accordance with the Animal Welfare Act and
other federal statutes and regulations relating to animals. All animals were housed at the
Yerkes National Primate Research Center (YNPRC) at Emory University (Atlanta, GA)
following the guidelines established by the National Institutes of Health (NIH), under the
supervision of the Association for the Assessment and Accreditation of Laboratory
Animal Care (AAALAC)-accredited Division of Animal Resources. Housing and care for
all animals complied with and met the standards established and written in the Animal
Welfare Act, Animal Welfare Regulations, and The Guide for the Care and Use of
Laboratory Animals (8thEdition). All tissue sample collections were performed under
anesthetization using Ketamine (10 mg/kg IM) or Telazol (5 mg/kg IM) to minimize
suffering. No pre-scheduled sacrifice or death of animals was occurred in this study.
Reduction of stress was provided through enrichment activities such foraging for grains,
KongTM toys, as well as other enrichment strategies to animals in need as determined by
the YNPRC veterinary and/or care staff. Additionally, animals were housed in paneled
cages so as to provide some social interaction and contact with one another including
grooming and other social activities, when feasible.
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Chapter 5.2 Animals
Eighteen healthy, SIV-uninfected, Mamu-A*01-positive (MHC-class I) Indian
rhesus were used in this study. RM selected for this study were 32-38 months old (males
(n=13) and females (n=5)), and Mamu B*01 and Mamu B*17-negative to exclude
animals with predispositions for control of viremia. Animals selected for the study were
quarantined for 30-45 days in accordance with the YNPRC IACUC prior to the start of
the study. Animals underwent staggered necropsy post SIV infection during acute
infection at 5, 10, 13, 20, or 41 days post-infection (dpi), or during chronic infection at
90dpi. Three animals were sacrificed at each indicated time point post-infection (Figure
2-1a and Figure 2-2a).

Chapter 5.3 Infection and monitoring viral load
All animals were infected with 500TCID50 SIVmac251 intravenous (iv) (10.8ng/mL
p27) (Nancy Miller, NIAID, NIH). Whole blood was collected by venous puncture into
EDTA blood collection tubes (BD, Franklin Lakes, NJ) for evaluating SIV viral loads.
Plasma viremia was monitored longitudinally in all animals using quantitative real time
PCR, with sensitivity of 60 copies/mL by the Emory University CFAR Virology Core
facilities as previously described (187).

118

Chapter 5.4 Viral sequencing and analysis
Blood plasma from two animals was evaluated between 10dpi and 90dpi for TatTL8 and Gag-CM9 epitope sequence monitoring. Virus inoculum stock was evaluated to
determine the frequencies of each epitope present at the time of infection. Between
40,000–80,000 vRNA copies were extracted from blood plasma samples and viral
inoculum stock using the Qiagen BioRobot EZ1 Workstation with EZ1 Virus Mini Kit
v2.0 (Qiagen, Valencia, CA). vRNA was subject to reverse transcription using MuLV
(SuperScript III) reverse transcriptase using the following primers; Tat-RT3: 5’ –
TGGGGATAATTTTACACAAGGC-3’ (188) and SMgag.R1: 5’CTACTGGTCTTCTCCAAAGAGAGAATTGA-3’ for analysis of TL8 and CM9
epitopes, respectively. Resampling of PCR products was avoided by obtained PCR end
point dilutions of each cDNA sample as previously described (189). Equal quantities of
cDNA from each sample were PCR amplified to achieve the desirable sampling depth.
Multiple bulk PCR reactions were performed and subsequently pooled to reach sufficient
cDNA volumes when necessary. cDNA samples were analyzed using MiSeq analysis and
amplification fragment lengths of roughly 2,035bp and 1,560bp were generated for TL8
and CM9 epitope coding regions, respectively. PCR primers used for TL8 region
amplification are as follows; 1st round, Fwd: smE660/mac251-int-F1 5’ATGAATTTTAAAAGAAGGGGAGGAA-3’, Rev: Tat-R2 5’CCCAAGTATCCCTATTCTTGGTTGCAC-3’ (188) and 2nd round, Fwd:
smE660/mac251-int-F2: 5’-AAGAAGGGGAGGAATAGGGGATATG-3’, Rev: Tat-R3
5’-GAGCAAGATGGCGATAAGCAG-3’ (188). PCR primers used for CM9 region
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amplification are as follows; 1st round, Fwd: SIV.R.F1 5’TCGCTCTGCGGAGAGGCTG-3’, and Rev: SMgag.R1 5’CTACTGGTCTTCTCCAAAGAGAGAATTGA-3’, and 2nd round, Fwd: SIV.R.F2 5’TGCGGAGAGGCTGGCAGATTGA-3’, Rev: SM.gag.R2 5’TCCAAAGAGAGAATTGAGGTGCAGCAA-3’. Raw sequence reads were translated
into amino acid sequences and aligned to the SIVmac251 reference sequence. Variations
in Tat-TL8 and Gag-CM9 epitopes were determined as compared to canonical Tat-TL8
(TTPESANL) and Gag-CM9 (CTPYDINQM) reference amino acid sequences. The
frequency of each detected epitope variant was determined using Geneious R9 software
(Geneious, Auckland, New Zealand). Changes in the distribution of canonical Tat-TL8
and Gag-CM9 sequences between virus inoculum stock and chronic phase of infection, at
90dpi, were monitored (Figure 2-3).

Chapter 5.5 Tissue collection and lymphocyte cryopreservation
All samples were collected at YNPRC and shipped overnight to the University of
Pennsylvania for processing the following day, with the exception of peripheral blood
collected for complete blood count and blood plasma viral load analysis. Tissues were
collected from each animal at the indicated time points pre- and post-infection (Figure
2-1a and Figure 2-2a). Peripheral blood, axillary and inguinal superficial lymph nodes
(sLN), and rectal biopsies (RB) were collected longitudinally from each animal, while
spleen and mesenteric lymph nodes (mLN) were collected at necropsy only. Peripheral
blood was collected by venous puncture into EDTA or sodium heparin blood collection
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tubes (BD, Franklin Lakes, NJ). Blood collection volumes were taken in the IACUC
approved sample volumes at the indicated time points pre- and post SIV infection.
Superficial LN samples were collected under general anesthesia by surgery at the
indicated time points pre- and post SIV infection. Samples were stored in sterile R-10
media (Rosewell Park media (RPMI) (Mediatech Inc, Manassas, VA), supplemented with
10% fetal bovine serum (FBS), Penicillin/Streptomycin, L-Glutamine, and kept at 2-8°C
until processing. RBs were collected under general anesthesia using a sigmoidoscope at
the indicated time points pre- and post SIV infection. Samples were stored in sterile R-10
media and kept at 2-8°C until processing. Mesenteric LNs, remaining sLN, and spleen
were collected at necropsy only. Samples were stored in sterile R-10 media and kept at 28°C until processing.

Chapter 5.6 Processing tissues
All tissue processing was done at the University of Pennsylvania in accordance
with University Environmental and Health Safety Guidelines under sterile conditions.
Rectal biopsies were processed to extract intraepithelial and lamina propria residing
lymphocytes by the University of Pennsylvania Human Immunology Core facility. The
extraction process included serial washes of biopsies with R-10 media plus collagenase
XI followed by percoll 65/30 gradient for separation of lymphocytes from contaminating
epithelial cells. Peripheral blood mononuclear cells were isolated from venous whole
blood collected using standard Ficoll-Paque PLUS (GE Healthcare, Pittsburgh, PA)
diluted to 90% in 1X Dulbecos Phosphate Buffered Saline (Mediatech Inc, Manassas,
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VA), and centrifuged at 350g for 20 minutes. Spleen and LN were processed by
mechanical disruption in 2% FBS in Dulbecos Phosphate Buffered Saline with 10U/mL
of DNAse I (Roche Life Sciences, Indianapolis, IN) for extraction of lymphocytes.
Splenocytes were subsequently treated with sterile ACK red cell lysis buffer (NH4Cl
0.15M, KHCO3 10mM, EDTA 0.1mM pH 7.2-7.4 in distilled deionized water). All
extracted lymphocytes with the exception of those extracted from RBs were immediately
cryopreserved in 10% DMSO (Fisher Scientific, Fair Lawn, NJ) in FBS (Gemini BioProducts, West Sacramento, CA) and stored at -150°C. All RB derived lymphocytes
were evaluated fresh.

Chapter 5.7 Lymphocyte stimulation
Cryopreserved lymphocytes from peripheral blood, mLN, sLN, and spleen were
thawed and rested overnight in sterile R-10 media plus 10U/mL DNAse I (Roche Life
Sciences, Indianapolis, IN) at 37°C, 5% CO2 and 95% humidity incubation conditions.
Lymphocytes from blood, sLN, mLN and spleen were stimulated as described in (190) at
1.0mL final volume in sterile R-10 media. Peptide concentrations for stimulation
conditions were 2µg/mL Tat-TL8 peptide (TTPESANL) or Gag-CM9 (CTPYDINQM)
(New England Peptide, Gardner, MA). Co-stimulation was added with peptides; 1µg/mL
anti-CD49d (9F10, Biolegend, San Diego, CA) and CD28-ECD (Clone CD28.2,
Beckman Coulter, Brea, CA) at the start of stimulation. Positive control samples were
stimulated using Staphylococcal Enterotoxin B (List Biological Laboratories, Campbell,
CA) at 1µg/mL. CD107a-BV421 (Biolegend, San Diego, CA) was added at the start of
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stimulation. Brefeldin A (1µg /mL) (Sigma Aldrich, Saint Louis, MO) and monensin
(0.66µL/mL) (BD Bioscience, San Jose, CA) were added one hour after initiation of
stimulation. Cells were incubated under stimulation conditions for a total of 9 hours.

Chapter 5.8 MHC Class I Tetramers
Tat-TL8 (TTPESANL) Mamu A*01-APC conjugated tetramers and Gag-CM9
(CTPYDINQM) Mamu A*01 monomers were supplied by the NIH Tetramer Core
Facility at Emory University, Atlanta, GA. Gag-CM9 Mamu A*01-BV421 tetramers
were prepared in our laboratory using Gag-CM9 monomers and streptavidin-BV421
(Biolegend, San Diego, CA) with protease inhibitor cocktail set I (Calbiochem, Billerica,
MA).

Chapter 5.9 Fluorescence cytometry staining
Lymphocytes were stained as described in (190). MHC class I, Mamu A*01
tetramer staining was done at 37°C at 5% CO2 and 95% humidity for 10 minutes,
concurrent with CCR7 staining when applicable, prior to the addition of viability dye and
remaining antibodies for immunophenotype staining.

Chapter 5.10 Antibodies
The following antibodies were used for phenotyping and functional evaluation of
lymphocytes in this study: CD107a-BV421 (H4A3, Biolegend), CD4-PECy5.5 (clone
S3.5, Invitrogen), CD8-BV570 (Clone RPA-T8, Biolegend), CD14-BV650 (clone M5E2,
123

Biolegend), CD20-BV650 (Clone 2H7, Biolegend), CD16-BV650 (Clone 3G8,
Biolegend), CD28-ECD (Clone CD28.2, Beckman Coulter), CD95-PECy5 (Dx2, BD
Biosciences), CD38-PE (OKT10, NIH NHP Reagent Resource, University of
Massachusetts, Boston, MA), CCR7- BV711 (G043H7, Biolegend). CD3-APCCy7
(SP34-2, BD Biosciences), granzyme B-AF700 (GB11, BD Biosciences), T-bet-PECy7
(4B10, eBioscience), Ki67-FITC (B56, BD Bioscience) or Ki67-BV786 (B56, BD
Bioscience), CD69-APC (FN50, BD Bioscience) or CD69-BV605 (FN50, Biolegend),
Perforin-FITC (pf344, MabTech), TNF-BV605 (MAb11, Biolegend), IFNγ-BV785
(4S.B3, Biolegend), Live Dead Fixable Aqua Dead Cell Stain (Molecular Probes).

Chapter 5.11 Data acquisition and analysis
All immunofluorescence stained lymphocytes were acquired and analyzed on a
special order LSR II Flow cytometer using BD FACS Diva Software version 6.0.1 or
8.0.1 (Becton Dickinson, San Jose, CA). Flow cytometry data was analyzed using
FlowJo version 9.8.3 (Treestar, Ashland, OR). Statistical analysis and graphs of flow
cytometry data were performed using JMP Pro 12 (SAS, Cary, NC) or Prism v5.0
(GraphPad Software, La Jolla, Ca). All reported values for functional response after
peptide stimulation were done with background (unstimulated) levels subtracted and with
a minimum of 10 events for functional response or 25 events for tetramer responses.
Analysis of paired samples, longitudinally or between matched tissues at a single time
point was done by paired student t-test with alpha 0.05. Regression ANOVA was done
on samples collected between 13dpi and 90dpi to monitor cross sectional changes over
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time. * indicates a p<0.05, ** indicates a p value <0.01, and *** indicates a p value
<0.001.
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